5. Referenzen

Abbas, A.K.; Lichtman, A.H. and Pober, J.S. (1994): Cellular and molecular immunology, W. B. Saunders, Philadelphia.

Abdalla, S.; Weatherall, D. J.; Wickramasinghe, S. N. and Hughes, M. (1980): The anaemia of P. falciparum malaria, Br J Haematol 46 [2], pp.171-83.

Abdalla, S.H.; Lorraine, P. and Hussein, H.A. (1990): The value of screening tests for glucose-6-phosphate dehydrogenase deficiency, Clinical and Laboratory Haematology 12, pp.77-86.

Abel, L.; Cot, M.; Mulder, L.; Carnevale, P. and Feingold, J. (1992): Segregation analysis detects a major gene controlling blood infection levels in human malaria, Am J Hum Genet 50 [6], pp.1308-17. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.ncbi.nlm.nih.gov/htbin-post/Omim/getmim%3ffield=medline_uid&search=1598911

Abraham, L. J. and Kroeger, K. M. (1999): Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease, J Leukoc Biol 66 [4], pp.562-6.

Adagu, I. S. and Warhurst, D. C. (1999): Association of cg2 and pfmdr1 genotype with chloroquine resistance in field samples of Plasmodium falciparum from Nigeria, Parasitology 119 [Pt 4], pp.343-8..

Ademowo, A.D.; Falusi, A.G. and Mewoyeka, O.D. (1995): Prevalence of asymptomatic parasitemia in an urban and rural community in south wester Nigeria, Central African Journal of Medicine 41 [1], pp.18-21.

Afari, E. A.; Akanmori, B. D.; Nakano, T. and Ofori-Adjei, D. (1992): Plasmodium falciparum: sensitivity to chloroquine in vivo in three ecological zones in Ghana, Trans R Soc Trop Med Hyg 86 [3], pp.231-2..

Aguado, B.; Bahram, S.; Beck, S.; Campbell, R.D.; Forbes, S.A.; Geraghty, D.; Guillaudeux, T.; Hood, L.; Horton, R.; Inoko, H.; Janer, M.; Jasoni, C.; Madan, A.; Milne, S.; Neville, M.; Oka, A.; Qin, S.; Ribas-Despuig, G.; Rogers, J.; Rowen, L.; Shiina, T.; Spies, T.; Tamiya, G.; Tashiro, H.; Trowsdale, J.; Vu, Q.; Williams, L. and Yamazaki, M. (1999): Complete sequence and gene map of a human major histocompatibility complex, Nature 401 [6756], pp.921-924.

Aidoo, M.; Lalvani, A.; Allsopp, C. E.; Plebanski, M.; Meisner, S. J.; Krausa, P.; Browning, M.; Morris-Jones, S.; Gotch, F.; Fidock, D. A. and et al. (1995): Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria, Lancet 345 [8956], pp.1003-7.

Aikawa, M.; Rabbege, J. R.; Udeinya, I. and Miller, L. H. (1983): Electron microscopy of knobs in Plasmodium falciparum-infected erythrocytes, J Parasitol 69 [2], pp.435-7.

Allen, S. J.; O'Donnell, A.; Alexander, N. D.; Alpers, M. P.; Peto, T. E. A.; Clegg, J. B. and Weatherall, D. J. (1997): alpha+-Thalassemia protects children against disease caused by other infections as well as malaria, Proc Natl Acad Sci U S A 94 [26], pp.14736-41. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.ncbi.nlm.nih.gov/htbin-post/Omim/getmim%3ffield=medline_uid&search=9405682

Allison, A.C. (1954): Protection affortded by sickle-cell trait against subtertian malarial infection, Br Med J i, pp.290-294.

Alonso, P. L.; Lindsay, S. W.; Armstrong, J. R.; Conteh, M.; Hill, A. G.; David, P. H.; Fegan, G.; de Francisco, A.; Hall, A. J.; Shenton, F. C. and et al. (1991): The effect of insecticide-treated bed nets on mortality of Gambian children, Lancet 337 [8756], pp.1499-502..

Amiel, J.L. (1967): Histocompatibility testing 1967, Curtoni, R.S.; Mattiuo, P.L. and Tosi, R.M., Eds, Muksgaard, Kopenhagen.

Anderson, T. J.; Haubold, B.; Williams, J. T.; Estrada-Franco Section Sign, J. G.; Richardson, L.; Mollinedo, R.; Bockarie, M.; Mokili, J.; Mharakurwa, S.; French, N.; Whitworth, J.; Velez, I. D.; Brockman, A. H.; Nosten, F.; Ferreira, M. U. and Day, K. P. (2000): Microsatellite markers reveal a spectrum of population structures in the malaria parasite plasmodium falciparum, Mol Biol Evol 17 [10], pp.1467-82. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.molbiolevol.org/cgi/content/full/17/10/1467

Anderson, T. J.; Su, X. Z.; Bockarie, M.; Lagog, M. and Day, K. P. (1999): Twelve microsatellite markers for characterization of Plasmodium falciparum from finger-prick blood samples, Parasitology 119 [Pt 2], pp.113-25.

Anderson, T. J.; Su, X. Z.; Roddam, A. and Day, K. P. (2000): Complex mutations in a high proportion of microsatellite loci from the protozoan parasite plasmodium falciparum, Mol Ecol 9 [10], pp.1599-608.

Anthony, T. G.; Trueman, H. E.; Harbach, R. E. and Vogler, A. P. (2000): Polymorphic microsatellite markers identified in individual Plasmodium falciparum oocysts from wild-caught Anopheles mosquitoes, Parasitology 121 [Pt 2], pp.121-6.

Archibald, C.P.; Mak, J.W.; Mathias, R.G. and Selvajothi, S. (1990): Antibodies to Plasmodium falciparum in an indigenous population from a malaria endemic area of Malaysia, Acta Tropica 48, pp.149-157.

Arellano, J.; Granados, J.; Perez, E.; Felix, C. and Kretschmer, R. R. (1991): Increased frequency of HLA-DR3 and complotype SC01 in Mexican mestizo patients with amoebic abscess of the liver, Parasite Immunol 13 [1], pp.23-9.

Arellano, J.; Isibasi, A.; Miranda, R.; Higuera, F.; Granados, J. and Kretschmer, R. R. (1987): HLA antigens associated to amoebic abscess of the liver in Mexican mestizos, Parasite Immunol 9 [6], pp.757-60.

Arese, P.; Cappadoro, M.; Giribaldi, G. and Turrini, F (1994): The Malaria/ G6PD Hypothesis Revisited: Reply, Parasitology Today 10, pp.262-263.

Arnot, D. E.; Roper, C. and Bayoumi, R. A. (1993): Digital codes from hypervariable tandemly repeated DNA sequences in the Plasmodium falciparum circumsporozoite gene can genetically barcode isolates, Mol Biochem Parasitol 61 [1], pp.15-24.

Atar, D.; Dyrberg, T.; Michelsen, B.; Karlsen, A.; Kofod, H.; Molvig, J. and Lernmark, A. (1989): Site-specific antibodies distinguish single amino acid substitutions in position 57 in HLA-DQ beta-chain alleles associated with insulin- dependent diabetes, J Immunol 143 [2], pp.533-8.

Atkinson, C. T.; Aikawa, M.; Aley, S. B. and Hollingdale, M. R. (1989): Expression of Plasmodium berghei circumsporozoite antigen on the surface of exoerythrocytic schizonts and merozoites, Am J Trop Med Hyg 41 [1], pp.9-17..

Ausubel, F.; Brent, R.; Kingston, R. E.; Moore, R. E.; Seidman, J. G.; Smith, J. A. and Struhl, K. (1992): Short protocols in molecular biology, 3. ed., Current protocols in molecular biology, Wiley.

Awomoyi, A. A.; Donn, R. P.; Davies, E. J.; Carthy, D.; Thomson, W. and Ollier, W. E. (1995): Absence of TAP 2D in Yoruba Nigerians, Eur J Immunogenet 22 [2], pp.187-90.

Babbitt, B. P.; Allen, P. M.; Matsueda, G.; Haber, E. and Unanue, E. R. (1985): Binding of immunogenic peptides to Ia histocompatibility molecules, Nature 317 [6035], pp.359-61.

Babiker, H. A.; Pringle, S. J.; Abdel-Muhsin, A.; Mackinnon, M.; Hunt, P. and Walliker, D. (2001): High-Level Chloroquine Resistance in Sudanese Isolates of Plasmodium falciparum Is Associated with Mutations in the Chloroquine Resistance Transporter Gene pfcrt and the Multidrug Resistance Gene pfmdr1, J Infect Dis 183 [10], pp.1535-8..

Baisch, J. M. and Capra, J. D. (1993): Linkage disequilibrium within the HLA complex does not extend into HLA- DP, Scand J Immunol 37 [4], pp.499-503.

Barker, R. H., Jr.; Banchongaksorn, T.; Courval, J. M.; Suwonkerd, W.; Rimwungtragoon, K. and Wirth, D. F. (1992): A simple method to detect Plasmodium falciparum directly from blood samples using the polymerase chain reaction, Am-J-Trop-Med-Hyg 46 [4], pp.416-26.

Barragan, A.; Kremsner, P. G.; Wahlgren, M. and Carlson, J. (2000): Blood group A antigen is a coreceptor in plasmodium falciparum rosetting, Infect Immun 68 [5], pp.2971-5. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://iai.asm.org/cgi/content/full/68/5/2971

Baruch, D. I.; Pasloske, B. L.; Singh, H. B.; Bi, X.; Ma, X. C.; Feldman, M.; Taraschi, T. F. and Howard, R. J. (1995): Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes, Cell 82 [1], pp.77-87.

Basco, L. K. and Ringwald, P. (2001): Analysis of the Key pfcrt Point Mutation and In Vitro and In Vivo Response to Chloroquine in Yaounde, Cameroon, J Infect Dis 183 [12], pp.1828-31..

Bate, C. A.; Taverne, J.; Karunaweera, N. D.; Mendis, K. N.; Kwiatkowski, D. and Playfair, J. H. (1992): Serological relationship of tumor necrosis factor-inducing exoantigens of Plasmodium falciparum and Plasmodium vivax, Infect Immun 60 [3], pp.1241-3.

Battistuzzi, G.; Esan, G.J.; Fasuan, F.A.; Modiano, G. and Luzzatto, L. (1977): Comparison of GdA and GdB activities in Nigerians. A study of the variation of the G6PD activity, American Journal of Human Genetics 29, pp.31-36.

Baysal, E. and Huisman, T.H. (1994): Detection of common deletional alpha-thalassemia-2 determinants by PCR, Am-J-Hematol 46 [3], pp.208-13.

Beck, H. P.; Felger, I.; Barker, M.; Bugawan, T.; Genton, B.; Alexander, N.; Jazwinska, E.; Erlich, H. and Alpers, M. (1995): Evidence of HLA class II association with antibody response against the malaria vaccine SPF66 in a naturally exposed population, Am J Trop Med Hyg 53 [3], pp.284-8.

Beck, S.; Kelly, A.; Radley, E.; Khurshid, F.; Alderton, R. P. and Trowsdale, J. (1992): DNA sequence analysis of 66 kb of the human MHC class II region encoding a cluster of genes for antigen processing, J Mol Biol 228 [2], pp.433-41.

Bellamy, R.; Kwiatkowski, D. and Hill, A. V. (1998): Absence of an association between intercellular adhesion molecule 1, complement receptor 1 and interleukin 1 receptor antagonist gene polymorphisms and severe malaria in a West African population, Trans R Soc Trop Med Hyg 92 [3], pp.312-6. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.ncbi.nlm.nih.gov/htbin-post/Omim/getmim%3ffield=medline_uid&search=9861406

Bennett, S.; Allen, S. J.; Olerup, O.; Jackson, D. J.; Wheeler, J. G.; Rowe, P. A.; Riley, E. M. and Greenwood, B. M. (1993): Human leucocyte antigen (HLA) and malaria morbidity in a Gambian community, Trans R Soc Trop Med Hyg 87 [3], pp.286-7.

Berendt, A. R.; Ferguson, D. J.; Gardner, J.; Turner, G.; Rowe, A.; McCormick, C.; Roberts, D.; Craig, A.; Pinches, R.; Elford, B. C. and et al. (1994): Molecular mechanisms of sequestration in malaria, Parasitology 108 [Suppl], pp.S19-28.

Berendt, A. R.; Simmons, D. L.; Tansey, J.; Newbold, C. I. and Marsh, K. (1989): Intercellular adhesion molecule-1 is an endothelial cell adhesion receptor for Plasmodium falciparum, Nature 341 [6237], pp.57-9.

Bergqvist, Y. and Frisk-Holmberg, M. (1980): Sensitive method for the determination of chloroquine and its metabolite desethylchloroquine in human plasma and urine by high performance liquid chromatography, J Chromatogr. [221], pp.119-227.

Beutler, E. (1975): Red cell metabolism. A manual of biochemical methods 62, Grune & ´Stratton, New York.

Beutler, E. (1978): Hemolytic Anemia in Disorders of Red Cell Metabolism, E, Beutler, Ed, The red cell, Plenum Medical Book Co, New York.

Beutler, E.; Kuhl, W.; Vives-Corrons, J.L. and Prchal, J.T. (1989): Molecular heterogeneity of glucose-6-phosphate dehydrogenase A-, Blood 74, pp.2550-2555.

Bidwell, J. (1994): Advances in DNA-based HLA-typing methods, Immunol Today 15 [7], pp.303-7.

Bienzle, U.; Ayeni, O.; Lucas, A.O. and Luzzatto, L. (1972): Glucose-6-phosphate dehydrogenase and malaria, Lancet i, pp.107-110.

Bienzle, U.; Guggenmoos-Holzmann, I. and Luzzatto, L. (1980): Plasmodium falciparum malaria and human red cells. I. Genetic and clinical study in children, International Journal of Epidemiology 10, pp.9-15.

Binka, F. N.; Kubaje, A.; Adjuik, M.; Williams, L. A.; Lengeler, C.; Maude, G. H.; Armah, G. E.; Kajihara, B.; Adiamah, J. H. and Smith, P. G. (1996): Impact of permethrin impregnated bednets on child mortality in Kassena- Nankana district, Ghana: a randomized controlled trial, Trop Med Int Health 1 [2], pp.147-54..

Birnboim, H. C. and Doly, J. (1979): A rapid alkaline extraction procedure for screening recombinant plasmid DNA, Nucleic Acids Res 7 [6], pp.1513-23.

Bjorkman, P. J. and Parham, P. (1990): Structure, function, and diversity of class I major histocompatibility complex molecules, Annu Rev Biochem 59, pp.253-88.

Bjorkman, P. J.; Saper, M. A.; Samraoui, B.; Bennett, W. S.; Strominger, J. L. and Wiley, D. C. (1987): Structure of the human class I histocompatibility antigen, HLA-A2, Nature 329 [6139], pp.506-12.

Bodmer, J.; Bodmer, W.; Heyes, J.; So, A.; Tonks, S.; Trowsdale, J. and Young, J. (1987): Identification of HLA-DP polymorphism with DP alpha and DP beta probes and monoclonal antibodies: correlation with primed lymphocyte typing, Proc Natl Acad Sci U S A 84 [13], pp.4596-600. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.ncbi.nlm.nih.gov/htbin-post/Omim/getmim%3ffield=medline_uid&search=2885841

Bodmer, W. F. (1972): Evolutionary significance of the HL-A system, Nature 237 [5351], pp.139-45 passim. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.ncbi.nlm.nih.gov/htbin-post/Omim/getmim%3ffield=medline_uid&search=4113158

Borre, M. B.; Dziegiel, M.; Hogh, B.; Petersen, E.; Rieneck, K.; Riley, E.; Meis, J. F.; Aikawa, M.; Nakamura, K.; Harada, M. and et al. (1991): Primary structure and localization of a conserved immunogenic Plasmodium falciparum glutamate rich protein (GLURP) expressed in both the preerythrocytic and erythrocytic stages of the vertebrate life cycle, Mol Biochem Parasitol 49 [1], pp.119-31.

Bottius, E.; BenMohamed, L.; Brahimi, K.; Gras, H.; Lepers, J. P.; Raharimalala, L.; Aikawa, M.; Meis, J.; Slierendregt, B.; Tartar, A.; Thomas, A. and Druilhe, P. (1996b): A novel Plasmodium falciparum sporozoite and liver stage antigen (SALSA) defines major B, T helper, and CTL epitopes, J Immunol 156 [8], pp.2874-84. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.jimmunol.org/cgi-bin/Retreiver.cgi/v156n8/2874/2874-abs-frame.html

Bottius, E.; Guanzirolli, A.; Trape, J.-F.; C., Rogier; Konate, L. and Druilhe, P. (1996a): Malaria: even more chronic in nature than previously thought: evidence for subpatent parasitemia detectable by PCR, Transactions of the Royal Society of Tropical Medicine and Hygiene 90, pp.15-19.

Bouharoun-Tayoun, H.; Attanath, P.; Sabchareon, A.; Chongsuphajaisiddhi, T. and Druilhe, P. (1990): Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes, J Exp Med 172 [6], pp.1633-41.

Bouharoun-Tayoun, H.; Oeuvray, C.; Lunel, F. and Druilhe, P. (1995): Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages, J Exp Med 182 [2], pp.409-18.

Boyd, M.F. and Kitchen, S.F. (1937): Simultaneous inoculation with Plasmodium vivax and Plasmodium falciparum, Am J Trop Med 17, pp.855-861.

Bradley-Moore, A. M.; Greenwood, B. M.; Bradley, A. K.; Akintunde, A.; Attai, E. D.; Fleming, A. F.; Bartlett, A.; Bidwell, D. E.; Voller, A.; Kirkwood, B. R. and et al. (1985): A comparison of chloroquine and pyrimethamine as malaria chemoprophylactics in young Nigerian children, Trans R Soc Trop Med Hyg 79 [5], pp.722-7.

Bradley-Moore, A. M.; Greenwood, B. M.; Bradley, A. K.; Akintunde, A.; Attai, E. D.; Fleming, A. F.; Flynn, F. V.; Kirkwood, B. R. and Gilles, H. M. (1985): Malaria chemoprophylaxis with chloroquine in young Nigerian children. IV. Its effect on haematological measurements, Ann Trop Med Parasitol 79 [6], pp.585-95..

Bradley-Moore, A. M.; Greenwood, B. M.; Bradley, A. K.; Bartlett, A.; Bidwell, D. E.; Voller, A.; Craske, J.; Kirkwood, B. R. and Gilles, H. M. (1985): Malaria chemoprophylaxis with chloroquine in young Nigerian children. II. Effect on the immune response to vaccination, Ann Trop Med Parasitol 79 [6], pp.563-73..

Bradley-Moore, A. M.; Greenwood, B. M.; Bradley, A. K.; Bartlett, A.; Bidwell, D. E.; Voller, A.; Kirkwood, B. R. and Gilles, H. M. (1985): Malaria chemoprophylaxis with chloroquine in young Nigerian children. I. Its effect on mortality, morbidity and the prevalence of malaria, Ann Trop Med Parasitol 79 [6], pp.549-62..

Bradley-Moore, A. M.; Greenwood, B. M.; Bradley, A. K.; Kirkwood, B. R. and Gilles, H. M. (1985): Malaria chemoprophylaxis with chloroquine in young Nigerian children. III. Its effect on nutrition, Ann Trop Med Parasitol 79 [6], pp.575-84..

Brandts, C. H.; Ndjave, M.; Graninger, W. and Kremsner, P. G. (1997): Effect of paracetamol on parasite clearance time in Plasmodium falciparum malaria, Lancet 350 [9079], pp.704-9.

Brinkman, B. M.; Zuijdeest, D.; Kaijzel, E. L.; Breedveld, F. C. and Verweij, C. L. (1995): Relevance of the tumor necrosis factor alpha (TNF alpha) -308 promoter polymorphism in TNF alpha gene regulation, J Inflamm 46 [1], pp.32-41.

Brown, J. H.; Jardetzky, T. S.; Gorga, J. C.; Stern, L. J.; Urban, R. G.; Strominger, J. L. and Wiley, D. C. (1993): Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1, Nature 364 [6432], pp.33-9.

Brown, K.N. (1990): The parasitology of malaria and the study of protective immunity, Immunol Lett 25, pp.97-99.

Bruce-Chwatt, L.J. (1963a): A longitudinal survey of malaria infection in a group of West African adults. II, West Africa Medical Journal 12, pp.199-217.

Bruce-Chwatt, L.J. (1963b): A longitudinal survey of malaria infection in a group of West African adults. I, West Africa Medical Journal 12, pp.141-173.

Bruce-Chwatt, L.J.; Dodge, J.S.; Draper, C.C.; Topley, E. and Voller, A. (1972): Sero-epidemiological studies on population groups previously exposed to malaria, Lancet 7749 (?), pp.512-516.

Bugawan, T. L.; Begovich, A. B. and Erlich, H. A. (1990): Rapid HLA-DPB typing using enzymatically amplified DNA and nonradioactive sequence-specific oligonucleotide probes, Immunogenetics 32 [4], pp.231-41.

Bugawan, T. L.; Horn, G. T.; Long, C. M.; Mickelson, E.; Hansen, J. A.; Ferrara, G. B.; Angelini, G. and Erlich, H. A. (1988): Analysis of HLA-DP allelic sequence polymorphism using the in vitro enzymatic DNA amplification of DP-alpha and DP-beta loci, J Immunol 141 [11], pp.4024-30.

Burbach, G.; May, J.; Harms, G. and Bienzle, U. (1999): [Leishmaniasis. Basic principles, clinical aspects, diagnosis and therapy], Dtsch Med Wochenschr 124 [4], pp.88-93.

Burchard, G.D.; Browne, E.N.L.; Sievertsen, J.; May, J. and Meyer, C.G. (im Druck): Spleen size determined by ultrasound in patients with AS trait, AC trait and G6PD deficiency in a hyperendemic malaria region (Ashanti Region/Ghana), Acta Tropica.

Burgner, D.; Xu, W.; Rockett, K.; Gravenor, M.; Charles, I. G.; Hill, A. V. and Kwiatkowski, D. (1998): Inducible nitric oxide synthase polymorphism and fatal cerebral malaria, Lancet 352 [9135], pp.1193-4.

Butcher, G. (1998): Cross-species immunity in malaria, Parasitology Today 14 [4], p.166.

Butcher, G. A. and Clark, I. A. (1990): The inhibition of Plasmodium falciparum growth in vitro by sera from mice infected with malaria or treated with TNF, Parasitology 101 Pt 3, pp.321-6.

Butcher, G. A.; Mitchell, G. H. and Cohen, S. (1978): Antibody mediated mechanisms of immunity to malaria induced by vaccination with Plasmodium knowlesi merozoites, Immunology 34 [1], pp.77-86.

Buus, S.; Sette, A.; Colon, S. M.; Miles, C. and Grey, H. M. (1987): The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides, Science 235 [4794], pp.1353-8.

Caballero, A.; Bravo, M. J.; Nieto, A.; Colmenero, J. D.; Alonso, A. and Martin, J. (2000): TNFA promoter polymorphism and susceptibility to brucellosis, Clin Exp Immunol 121 [3], pp.480-3..

Cabrera, M.; Shaw, M. A.; Sharples, C.; Williams, H.; Castes, M.; Convit, J. and Blackwell, J. M. (1995): Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis, J Exp Med 182 [5], pp.1259-64.. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.ncbi.nlm.nih.gov/htbin-post/Omim/getmim%3ffield=medline_uid&search=7595196

Calvo-Calle, J.M.; Hammer, J.; Sinigaglia, F.; Clavijo, P.; Moya-Castro, Z.R. and Nardin, E.H. (1997): Binding of malaria T cell epitopes to DR and DQ molecules in vitro correlates with immunogenicity in vivo, J Immunol 159, pp.1362-1373.

Cannings, C. and Cavalli-Sforza, L. (1973): Human population structure, Adv Hum Genet 4, pp.105-71.

Carlson, J. (1999): Inborn resistance to malaria, Wahlgren, M. and Perlmann, P., Eds, Malaria - molecular and clinical aspects, pp. 363-378, Harwood Academic Publishers, Amsterdam.

Carlson, J.; Helmby, H.; Hill, A. V.; Brewster, D.; Greenwood, B. M. and Wahlgren, M. (1990): Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies, Lancet 336 [8729], pp.1457-60.

Ceman, S.; Rudersdorf, R. A.; Petersen, J. M. and DeMars, R. (1995): DMA and DMB are the only genes in the class II region of the human MHC needed for class II-associated antigen processing, J Immunol 154 [6], pp.2545-56.

Charoenvit, Y.; Mellouk, S.; Sedegah, M.; Toyoshima, T.; Leef, M.F.; de la Vefa, P.; Beaudoin, R.L.; Aikawa, M.; Fallarme, V. and Hoffman, S.L. (1995): 17 kDa Plasmodium yoelii hepatic and erythrocytic stage protein is the target of protective antibodies, Exp Parasitology 80 [419-429].

Chauffert, M.; Cisse, A.; Chevenne, D.; You, J. F.; Michel, S. and Trivin, F. (1997): Susceptibility to type 1 diabetes in the Senegalese population is linked to HLA-DQ and not TAP and LMP genes, Diabetes Care 20 [8], pp.1299-303.

Chen, N.; Russell, B.; Staley, J.; Kotecka, B.; Nasveld, P. and Cheng, Q. (2001): Sequence Polymorphisms in pfcrt Are Strongly Associated with Chloroquine Resistance in Plasmodium falciparum, J Infect Dis 183 [10], pp.1543-5..

Cheng, Q.; Lawrence, G.; Reed, C.; Stowers, A.; Ranford-Cartwright, L.; Creasey, A.; Carter, R. and Saul, A. (1997): Measurement of Plasmodium falciparum growth rate in vivo: a test of malaria vaccines, Am J Trop Med Hyg 57, pp.495-500.

Church, G. M. and Gilbert, W. (1985): The genomic sequencing technique, Prog Clin Biol Res 177, pp.17-21.

Clark, I. A. and Hunt, N. H. (1983): Evidence for reactive oxygen intermediates causing hemolysis and parasite death in malaria, Infect Immun 39 [1], pp.1-6.

Clegg, J. B. and Weatherall, D. J. (1999): Thalassemia and malaria: new insights into an old problem, Proc Assoc Am Physicians 111 [4], pp.278-82.

Clendennen, T.E.; Long, G.W. and Baird, J.K. (1995): QBC® and Giemsa-stained thick blood films: diagnostic performance of laboratory technologists, Transactions of the Royal Society of Tropical Medicine and Hygiene 87, pp.649-653.

Clyde, D. F.; McCarthy, V. C.; Miller, R. M. and Hornick, R. B. (1973): Specificity of protection of man immunized against sporozoite-induced falciparum malaria, Am J Med Sci 266 [6], pp.398-403..

Cohen, J.E. (1973): Heterologous immunity in human malaria, Quarterly Review of Biology, pp.467-489.

Cohen, S.; McGregor, I. A. and Carrington, S. P. (1961): Gammaglobulin and acquired immunity to malaria, Garnham, P. C.; Pierce, A. E. and Roitt, I., Eds, Immunity to protozoa, pp. 123-159, Blackwell Scientific Publications, Oxford, United Kingdom.

Collins, W. E.; Skinner, J. C.; Richardson, B. B. and Stanfill, P. S. (1975): Studies on the transmission of simian malaria. VI. Mosquito infection and sporozoite transmission of Plasmodium fragile, J Parasitol 61 [4], pp.718-21.

Colorado, I. A.; Acquatella, H.; Catalioti, F.; Fernandez, M. T. and Layrisse, Z. (2000): HLA class II DRB1, DQB1, DPB1 polymorphism and cardiomyopathy due to Trypanosoma cruzi chronic infection, Hum Immunol 61 [3], pp.320-5.

Connelly, M.; King, C. L.; Bucci, K.; Walters, S.; Genton, B.; Alpers, M. P.; Hollingdale, M. and Kazura, J. W. (1997): T-cell immunity to peptide epitopes of liver-stage antigen 1 in an area of Papua New Guinea in which malaria is holoendemic, Infect Immun 65 [12], pp.5082-7.

Contamin, H.; Fandeur, T.; Bonnefoy, S.; Skouri, F.; Ntoumi, F. and Mercereau Puijalon, O. (1995): PCR typing of field isolates of Plasmodium falciparum, J-Clin-Microbiol 33 [4], pp.944-51.

Conway, D.J. (1997): Natural selection on polymorphic malaria antigens and the search for a vaccine, Parasitology Today 13 [1], pp.26-29.

Conway, D. J.; Greenwood, B. M. and McBride, J. S. (1992): Longitudinal study of Plasmodium falciparum polymorphic antigens in a malaria-endemic population, Infect Immun 60 [3], pp.1122-7.

Conway, D. J.; Holland, M. J.; Bailey, R. L.; Campbell, A. E.; Mahdi, O. S.; Jennings, R.; Mbena, E. and Mabey, D. C. (1997): Scarring trachoma is associated with polymorphism in the tumor necrosis factor alpha (TNF-alpha) gene promoter and with elevated TNF-alpha levels in tear fluid, Infect Immun 65 [3], pp.1003-6.. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.ncbi.nlm.nih.gov/htbin-post/Omim/getmim%3ffield=medline_uid&search=9038309

Copeman, J.; Bangia, N.; Cross, J. C. and Cresswell, P. (1998): Elucidation of the genetic basis of the antigen presentation defects in the mutant cell line .220 reveals polymorphism and alternative splicing of the tapasin gene, Eur J Immunol 28 [11], pp.3783-91.

Coppel, R. L.; Brown, G. V. and Nussenzweig, V. (1998): Adhesive proteins of the malaria parasite, Curr Opin Microbiol 1 [4], pp.472-81. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.biomednet.com/article/JMCR.mc1409 http://www.biomednet.com/article/JMCR.mc1409

Cowman, A.F. (1998): The molecular basis of resistance to the sulfones, sulfonamides, and dihydrofolate reductase inhibitors, Sherman, I.W., Ed, Malaria: Parasite biology, pathogenesis, and protection, pp. 317-330, ASM Press, Washington, D.C..

Cowman, A. F.; Morry, M. J.; Biggs, B. A.; Cross, G. A. and Foote, S. J. (1988): Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum, Proc Natl Acad Sci U S A 85 [23], pp.9109-13.

Craig, A. G.; Pinches, R.; Khan, S.; Roberts, D. J.; Turner, G. D.; Newbold, C. I. and Berendt, A. R. (1997): Failure to block adhesion of Plasmodium falciparum-infected erythrocytes to ICAM-1 with soluble ICAM-1, Infect Immun 65 [11], pp.4580-5.

Crane, G.G. (1986): Hyperreactive malaria splenomegaly (Tropical Spenomegaly Syndrome), Parasitol Today 2, pp.4-9.

Creasey, A.; Fenton, B.; Walker, A.; Thaithong, S.; Oliveira, S.; Mutambu, S. and Walliker, D. (1990): Genetic diversity of Plasmodium falciparum shows geographical variation, Am J Trop Med Hyg 42 [5], pp.403-13.

Cresswell, P.; Bangia, N.; Dick, T. and Diedrich, G. (1999): The nature of the MHC class I peptide loading complex, Immunol Rev 172, pp.21-8.

Croft, M. (1994): Activation of naive, memory and effector T cells, Curr Opin Immunol 6 [3], pp.431-7.

Curtis, J.; Duraisingh, M. T.; Trigg, J. K.; Mbwana, H.; Warhurst, D. C. and Curtis, C. F. (1996): Direct evidence that asparagine at position 108 of the Plasmodium falciparum dihydrofolate reductase is involved in resistance to antifolate drugs in Tanzania, Trans R Soc Trop Med Hyg 90 [6], pp.678-80..

Curtis, J.; Duraisingh, M. T. and Warhurst, D. C. (1998): In vivo selection for a specific genotype of dihydropteroate synthetase of Plasmodium falciparum by pyrimethamine-sulfadoxine but not chlorproguanil-dapsone treatment, J Infect Dis 177 [5], pp.1429-33..

D'Alessandro, U. and Coosemans, M. (1997): Concerns on long-term efficacy of an insecticide-treated bednet programme on child mortality, Parasitology Today 13, pp.124-125.

D'Alessandro, U.; Olaleye, B. O.; McGuire, W.; Langerock, P.; Bennett, S.; Aikins, M. K.; Thomson, M. C.; Cham, M. K.; Cham, B. A. and Greenwood, B. M. (1995): Mortality and morbidity from malaria in Gambian children after introduction of an impregnated bednet programme, Lancet 345 [8948], pp.479-83..

D'Alfonso, S. and Richiardi, P. M. (1994): A polymorphic variation in a putative regulation box of the TNFA promoter region, Immunogenetics 39 [2], pp.150-4. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.ncbi.nlm.nih.gov/htbin-post/Omim/getmim%3ffield=medline_uid&search=7903959

Daniel, S.; Brusic, V.; Caillat-Zucman, S.; Petrovsky, N.; Harrison, L.; Riganelli, D.; Sinigaglia, F.; Gallazzi, F.; Hammer, J. and van Endert, P. M. (1998): Relationship between peptide selectivities of human transporters associated with antigen processing and HLA class I molecules, J Immunol 161 [2], pp.617-24. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.jimmunol.org/cgi-bin/Retreiver.cgi/v161n2/617/617-abs-frame.html

Dausset, J. (1954): Leuco-agglutinins IV. Leuco-agglutinins and blood transfusion, Vox Sang 4, pp.190-198.

David, P. H.; Handunnetti, S. M.; Leech, J. H.; Gamage, P. and Mendis, K. N. (1988): Rosetting: a new cytoadherence property of malaria-infected erythrocytes, Am J Trop Med Hyg 38 [2], pp.289-97.

Davis, M. M. and Bjorkman, P. J. (1988): T-cell antigen receptor genes and T-cell recognition [published erratum appears in Nature 1988 Oct 20;335(6192):744], Nature 334 [6181], pp.395-402. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.ncbi.nlm.nih.gov/htbin-post/Omim/getmim%3ffield=medline_uid&search=3043226

de Arruda Mayr, M.; Cochrane, A. H. and Nussenzweig, R. S. (1979): Enhancement of a simian malarial infection (Plasmodium cynomolgi) in mosquitoes fed on rhesus (Macaca mulatta) previously infected with an unrelated malaria (Plasmodium knowlesi), Am J Trop Med Hyg 28 [4], pp.627-33.

de Kossodo, S. and Grau, G. E. (1993): Profiles of cytokine production in relation with susceptibility to cerebral malaria, J Immunol 151 [9], pp.4811-20.

de la Cruz, V. F.; Lal, A. A. and McCutchan, T. F. (1987): Sequence variation in putative functional domains of the circumsporozoite protein of Plasmodium falciparum. Implications for vaccine development, J Biol Chem 262 [25], pp.11935-9.

Deficiency, WHO Working Group on Glucose-6-Phosphate Dehydrogenase (1989): Glucose-6-Phosphate dehydrogenase deficiency, Bulletin of the World Health Organization WHO 67 [6], pp.601-611.

Deitsch, K. W.; Moxon, E. R. and Wellems, T. E. (1997): Shared themes of antigenic variation and virulence in bacterial, protozoal, and fungal infections, Microbiol Mol Biol Rev 61 [3], pp.281-93.

Denzin, L. K. and Cresswell, P. (1995): HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading, Cell 82 [1], pp.155-65.

Destro-Bisol, G.; Vienna, A.; Battaggia, C.; Paoli, G. and Spedini, G. (1999): Testing a biochemical model of human genetic resistance to falciparum malaria by the analysis of variation at protein and microsatellite loci, Hum Biol 71 [3], pp.315-32.

Dieye, A.; Rogier, C.; Trape, J.-F.; Sarthou, J.-L. and Druilhe, P. (1997): HLA class I-associated resistance to severe malaria: a parasitological re-assessment, Parasitology Today 13 [2], pp.48-49.

Djimde, A.; Doumbo, O. K.; Cortese, J. F.; Kayentao, K.; Doumbo, S.; Diourte, Y.; Dicko, A.; Su, X. Z.; Nomura, T.; Fidock, D. A.; Wellems, T. E.; Plowe, C. V. and Coulibaly, D. (2001): A molecular marker for chloroquine-resistant falciparum malaria, N Engl J Med 344 [4], pp.257-63.. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.nejm.org/content/scripts/search/page.asp%3fvolume=344&page=257

Doolan, D. L.; Hoffman, S. L.; Southwood, S.; Wentworth, P. A.; Sidney, J.; Chesnut, R. W.; Keogh, E.; Appella, E.; Nutman, T. B.; Lal, A. A.; Gordon, D. M.; Oloo, A. and Sette, A. (1997): Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles, Immunity 7 [1], pp.97-112. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.immunity.com/cgi/content/full/7/1/97

Doolan, D. L.; Sedegah, M.; Hedstrom, R. C.; Hobart, P.; Charoenvit, Y. and Hoffman, S. L. (1996): Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity, J Exp Med 183 [4], pp.1739-46.

Dorsey, G.; Kamya, M. R.; Singh, A. and Rosenthal, P. J. (2001): Polymorphisms in the Plasmodium falciparum pfcrt and pfmdr-1 Genes and Clinical Response to Chloroquine in Kampala, Uganda, J Infect Dis 183 [9], pp.1417-20..

Doumbo, O. K.; Kayentao, K.; Djimde, A.; Cortese, J. F.; Diourte, Y.; Konare, A.; Kublin, J. G. and Plowe, C. V. (2000): Rapid selection of plasmodium falciparum dihydrofolate reductase mutants by pyrimethamine prophylaxis, J Infect Dis 182 [3], pp.993-6.

Druilhe, P. and Marchand, C. (1989): From sporozoite to liver stages: the saga of the irradiated sporozoite vaccine, McAdam, K., Ed, New strategies in parasitology, pp. 39-48, Churchill Livingstone, Edinburgh, United Kingdom.

Druilhe, P. and Perignon, J. L. (1994): Mechanisms of defense against P. falciparum asexual blood stages in humans, Immunol Lett 41 [2-3], pp.115-20.

Druilhe, P. and Pérignon, J.L. (1997): A hypothesis about the chronicity of malaria infection, Parasitology Today 13 [9], pp.353-357.

Druilhe, P.; Pradier, O.; Marc, J. P.; Miltgen, F.; Mazier, D. and Parent, G. (1986): Levels of antibodies to Plasmodium falciparum sporozoite surface antigens reflect malaria transmission rates and are persistent in the absence of reinfection, Infect Immun 53 [2], pp.393-7.

Druilhe, P. L.; Rénia, L. and Fidock, D. A. (1998): Immunity to liver stages, Sherman, I.W., Ed, Malaria - parasite biology, pathogenesis, and protection, 1. ed., pp. 513-544, ASM Press, Washington.

Dunstan, S. J.; Stephens, H. A.; Blackwell, J. M.; Duc, C. M.; Lanh, M. N.; Dudbridge, F.; Phuong, C. X.; Luxemburger, C.; Wain, J.; Ho, V. A.; Hien, T. T.; Farrar, J. and Dougan, G. (2001): Genes of the Class II and Class III Major Histocompatibility Complex Are Associated with Typhoid Fever in Vietnam, J Infect Dis 183 [2], pp.261-268..

Dyer, P. A. and Martin, S. (1991): Techniques used to define human MHC antigens: serology, Immunol Lett 29 [1-2], pp.15-21.

Eckels, D. D.; Lake, P.; Lamb, J. R.; Johnson, A. H.; Shaw, S.; Woody, J. N. and Hartzman, R. J. (1983): SB-restricted presentation of influenza and herpes simplex virus antigens to human T-lymphocyte clones, Nature 301 [5902], pp.716-8. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.ncbi.nlm.nih.gov/htbin-post/Omim/getmim%3ffield=medline_uid&search=6186920

Egwunyenga, O.A.; Ajayi, J.A. and Duhlinka-Popova, D.D. (1997): Malaria in pregnancy in Nigerians: seasonality and relationship to splenomegaly and anaemia, Indian Journal of Malariology 34, pp.17-24.

Eiermann, T. H.; Bettens, F.; Tiberghien, P.; Schmitz, K.; Beurton, I.; Bresson-Hadni, S.; Ammann, R. W.; Goldmann, S. F.; Vuitton, D. A.; Gottstein, B. and Kern, P. (1998): HLA and alveolar echinococcosis, Tissue Antigens 52 [2], pp.124-9.

Elhassan, I.M.; Hviid, L.; Jakobsen, P.H.; Giha, H.; Satti, G.M.H.; Arnot, D.E.; Jensen, J.B. and Theander, T.G. (1995): High proportion of subclinical Plasmodium falciparum infections in an area of seasonal and unstable malaria in Sudan, American Journal of Tropical Medicine and Hygiene 53, pp.78-83.

Engelbrecht, F.; Felger, I.; Genton, B.; Alpers, M. and Beck, H. P. (1995): Plasmodium falciparum: malaria morbidity is associated with specific merozoite surface antigen 2 genotypes, Exp Parasitol 81 [1], pp.90-6.

Erlich, H.A. (1989): PCR Technology, Stockton Press, New York.

Erlich, H. A. and Gyllensten, U. B. (1991): Shared epitopes among HLA class II alleles: gene conversion, common ancestry and balancing selection, Immunol Today 12 [11], pp.411-4.

Esan, G.J. (1975): Haematological aspects of malaria, Clinics in Haematology 4, pp.247-256.

Escalante, A. A.; Lal, A. A. and Ayala, F. J. (1998): Genetic polymorphism and natural selection in the malaria parasite Plasmodium falciparum, Genetics 149 [1], pp.189-202. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.genetics.org/cgi/content/full/149/1/189 http://www.genetics.org/cgi/content/full/149/1/189

Esquivel, F.; Yewdell, J. and Bennink, J. (1992): RMA/S cells present endogenously synthesized cytosolic proteins to class I-restricted cytotoxic T lymphocytes, J Exp Med 175 [1], pp.163-8.

Facer, C. A. (1980): Direct antiglobulin reactions in Gambian children with P. falciparum malaria. III. Expression of IgG subclass determinants and genetic markers and association with anaemia, Clin Exp Immunol 41 [1], pp.81-90.

Facer, C. A.; Bray, R. S. and Brown, J. (1979): Direct Coombs antiglobulin reactions in Gambian children with Plasmodium falciparum malaria. I. Incidence and class specificity, Clin Exp Immunol 35 [1], pp.119-27.

Falchuk, Z. M.; Rogentine, G. N. and Strober, W. (1972): Predominance of histocompatibility antigen HL-A8 in patients with gluten-sensitive enteropathy, J Clin Invest 51 [6], pp.1602-5. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.ncbi.nlm.nih.gov/htbin-post/Omim/getmim%3ffield=medline_uid&search=5024049

Farnert, A.; Snounou, G.; Rooth, I. and Bjorkman, A. (1997): Daily dynamics of Plasmodium falciparum subpopulations in asymptomatic children in a holoendemic area, Am J Trop Med Hyg 56 [5], pp.538-547.

Fenton, B.; Clark, J. T.; Khan, C. M.; Robinson, J. V.; Walliker, D.; Ridley, R.; Scaife, J. G. and McBride, J. S. (1991): Structural and antigenic polymorphism of the 35- to 48-kilodalton merozoite surface antigen (MSA-2) of the malaria parasite Plasmodium falciparum, Mol Cell Biol 11 [2], pp.963-74.

Ferdig, M. T. and Su, X. Z. (2000): Microsatellite markers and genetic mapping in Plasmodium falciparum, Parasitol Today 16 [7], pp.307-12. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.biomednet.com/library/fulltext/PT.etd00369_01694758_v0016i07_00001676

Fernandez-Mestre, M. T.; Layrisse, Z.; Montagnani, S.; Acquatella, H.; Catalioti, F.; Matos, M.; Balbas, O.; Makhatadze, N.; Dominguez, E.; Herrera, F. and Madrigal, A. (1998): Influence of the HLA class II polymorphism in chronic Chagas' disease, Parasite Immunol 20 [4], pp.197-203.

Fernandez-Reyes, D.; Craig, A. G.; Kyes, S. A.; Peshu, N.; Snow, R. W.; Berendt, A. R.; Marsh, K. and Newbold, C. I. (1997): A high frequency African coding polymorphism in the N-terminal domain of ICAM-1 predisposing to cerebral malaria in Kenya, Hum Mol Genet 6 [8], pp.1357-60. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.ncbi.nlm.nih.gov/htbin-post/Omim/getmim%3ffield=medline_uid&search=9259284 http://www.oup.co.uk/hmg/Volume_06/Issue_08/dda161_gml.abs.html

Ferrante, A.; Kumaratilake, L.; Rzepczyk, C. M. and Dayer, J. M. (1990): Killing of Plasmodium falciparum by cytokine activated effector cells (neutrophils and macrophages), Immunol Lett 25 [1-3], pp.179-87.

Fidock, A. D.; Nomura, T.; Talley, K. A.; Cooper, A. R.; Dzekunov, M. S.; Ferdig, T. M.; Ursos, M. L.; Sidhu, A. B.; Naude, B.; Deitsch, W. K.; Su, Z. X.; Wootton, C. J.; Roepe, D. P. and Wellems, E. T. (2000): Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance., Mol Cell 6 [4], pp.861-71.

Fidock, D. A.; Bottius, E.; Brahimi, K.; Moelans, II; Aikawa, M.; Konings, R. N.; Certa, U.; Olafsson, P.; Kaidoh, T.; Asavanich, A.; Guérin-Marchand, C. and Druilhe, P. (1994a): Cloning and characterization of a novel Plasmodium falciparum sporozoite surface antigen, STARP, Mol Biochem Parasitol 64 [2], pp.219-32.

Fidock, D. A.; Gras-Masse, H.; Lepers, J. P.; Brahimi, K.; Benmohamed, L.; Mellouk, S.; Guerin-Marchand, C.; Londono, A.; Raharimalala, L.; Meis, J. F. and et al. (1994c): Plasmodium falciparum liver stage antigen-1 is well conserved and contains potent B and T cell determinants, J Immunol 153 [1], pp.190-204.

Fidock, D. A.; Nomura, T.; Cooper, R. A.; Su, X.; Talley, A. K. and Wellems, T. E. (2000): Allelic modifications of the cg2 and cg1 genes do not alter the chloroquine response of drug-resistant Plasmodium falciparum, Mol Biochem Parasitol 110 [1], pp.1-10..

Fidock, D. A.; Sallenave-Sales, S.; Sherwood, J. A.; Gachihi, G. S.; Ferreira-da-Cruz, M. F.; Thomas, A. W. and Druilhe, P. (1994b): Conservation of the Plasmodium falciparum sporozoite surface protein gene, STARP, in field isolates and distinct species of Plasmodium, Mol Biochem Parasitol 67 [2], pp.255-67.

Fischer, P. R. and Boone, P. (1998): Short report: severe malaria associated with blood group, Am J Trop Med Hyg 58 [1], pp.122-3.

Fitch, C. D. (1970): Plasmodium falciparum in owl monkeys: drug resistance and chloroquine binding capacity, Science 169 [942], pp.289-90..

Fleming, A.F. (1981): Haematological manifestations of malaria and other parasitic diseases, Clinics in Haematology 10, pp.983-1011.

Fling, S. P.; Arp, B. and Pious, D. (1994): HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells, Nature 368 [6471], pp.554-8. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.ncbi.nlm.nih.gov/htbin-post/Omim/getmim%3ffield=medline_uid&search=8139690

Flint, J.; Harding, R. M.; Boyce, A. J. and Clegg, J. B. (1998): The population genetics of the haemoglobinopathies, Baillieres Clin Haematol 11 [1], pp.1-51.

Flint, J.; Hill, A. V.; Bowden, D. K.; Oppenheimer, S. J.; Sill, P. R.; Serjeantson, S. W.; Bana-Koiri, J.; Bhatia, K.; Alpers, M. P.; Boyce, A. J. and et al. (1986): High frequencies of alpha-thalassaemia are the result of natural selection by malaria, Nature 321 [6072], pp.744-50. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.ncbi.nlm.nih.gov/htbin-post/Omim/getmim%3ffield=medline_uid&search=3713863

Fogel, B.J.; Shields, C.E. and Von Doenhoff, A.E. (1966): The osmotic fragility of erythrocytes in experimental malaria, Am J Trop Med Hyg 15, pp.269-275.

Foote, S. J.; Galatis, D. and Cowman, A. F. (1990): Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance, Proc Natl Acad Sci U S A 87 [8], pp.3014-7..

Foote, S. J.; Thompson, J. K.; Cowman, A. F. and Kemp, D. J. (1989): Amplification of the multidrug resistance gene in some chloroquine- resistant isolates of P. falciparum, Cell 57 [6], pp.921-30..

Fraile, A.; Vinasco, J.; Nieto, A.; Pareja, E. and Martin, J. (1996): Typing for TAP alleles using PCR-RFLP with amplification-created restriction sites, Tissue Antigens 47 [4], pp.346-52.

Franco, A.; Barnaba, V.; Natali, P.; Balsano, C.; Musca, A. and Balsano, F. (1988): Expression of class I and class II major histocompatibility complex antigen on human hepatocytes, Hepatology 8, p.449.

Friedman, M.J. (1979): Oxidant damage mediates variant red cell resistance to malaria, Nature 280, pp.245-251.

Früh, K. and Yang, Y. (1999): Antigen presentation by MHC class I and its regulation by interferon gamma, Curr Opin Immunol 11 [1], pp.76-81. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.biomednet.com/article/imb106

Furukawa, H.; Kashiwase, K.; Yabe, T.; Ishikawa, Y.; Akaza, T.; Tadokoro, K.; Tohma, S.; Inoue, T.; Tokunaga, K.; Yamamoto, K. and Juji, T. (1998): Polymorphism of TAPASIN and its linkage disequilibria with HLA class II genes in the Japanese population, Tissue Antigens 52 [3], pp.279-81.

Furukawa, H.; Murata, S.; Yabe, T.; Shimbara, N.; Keicho, N.; Kashiwase, K.; Watanabe, K.; Ishikawa, Y.; Akaza, T.; Tadokoro, K.; Tohma, S.; Inoue, T.; Tokunaga, K.; Yamamoto, K.; Tanaka, K. and Juji, T. (1999): Splice acceptor site mutation of the transporter associated with antigen processing-1 gene in human bare lymphocyte syndrome, J Clin Invest 103 [5], pp.755-8.

Galiano, S.; Gaetani, G. F.; Barabino, A.; Cottafava, F.; Zeitlin, H.; Town, M. and Luzzatto, L. (1990): Favism in the African type of glucose-6-phosphate dehydrogenase deficiency (A-), British Medical Journal 300 [6719],p.236.

Garcia, A.; Cot, M.; Chippaux, J. P.; Ranque, S.; Feingold, J.; Demenais, F. and Abel, L. (1998): Genetic control of blood infection levels in human malaria: evidence for a complex genetic model, Am J Trop Med Hyg 58 [4], pp.480-8.

Gardiner, C.; Biggar, H.J.; Collins, W.E. and Nkrumah, F.K. (1984): Malaria in urban and rural areas of Southern Ghana, a survey of parasitemia, antobodies and antimalarial practice, Bull WHO 62, pp.607-613.

Garnham, P.C.C. (1966): Malaria parasites and other haemosporidia, Blackwell, Oxford.

Gilbert, S. C.; Plebanski, M.; Gupta, S.; Morris, J.; Cox, M.; Aidoo, M.; Kwiatkowski, D.; Greenwood, B. M.; Whittle, H. C. and Hill, A. V. (1998): Association of malaria parasite population structure, HLA, and immunological antagonism, Science 279 [5354], pp.1173-7. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.sciencemag.org/cgi/content/full/279/5354/1173

Giles, R. C. and Capra, J. D. (1985): Structure, function, and genetics of human class II molecules, Adv Immunol 37, pp.1-71.

Gilles, H. (1986): Tropical clinical epidemiology--'a new name for an old art', Trans R Soc Trop Med Hyg 80 [3], pp.353-9.

Gilles, H.M. (1981): Normal haematological values in tropical areas, Clinical Haematology 10 [697-706].

Gilles, H.M. (1991): Management of severe and complicated malaria, 1. ed., World Health Organization, Geneva.

Gilles, H.M.; Fletcher, K.A.; Hendrickse, R.G.; Lindner, R.; Reddu, S. and Allan, N. (1967): Glucose-6-phosphate dehydrogenase, sickling and malaria in African children in Southwestern Nigeria, Lancet i, pp.138-140.

Glynne, R.; Powis, S. H.; Beck, S.; Kelly, A.; Kerr, L. A. and Trowsdale, J. (1991): A proteasome-related gene between the two ABC transporter loci in the class II region of the human MHC [see comments], Nature 353 [6342], pp.357-60. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.ncbi.nlm.nih.gov/htbin-post/Omim/getmim%3ffield=medline_uid&search=1922342

Goldfeld, A. E. and Tsai, E. Y. (1996): TNF-alpha and genetic susceptibility to parasitic disease, Exp Parasitol 84 [2], pp.300-3. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.idealibrary.com/links/citation/0014-4894/84/300

Good, M. F. and Doolan, D. L. (1999): Immune effector mechanisms in malaria, Current Opinion in Immunology 11, pp.412-419.

Good, M. F.; Kaslow, D. C. and Miller, L. H. (1998): Pathways and strategies for developing a malaria blood-stage vaccine, Annu Rev Immunol 16, pp.57-87.

Good, M. F. and Miller, L. H. (1990): T-cell antigens and epitopes in malaria vaccine design, Curr Top Microbiol Immunol 155, pp.65-78.

Goodyer, I. D. and Taraschi, T. F. (1997): Plasmodium falciparum: a simple, rapid method for detecting parasite clones in microtiter plates, Exp Parasitol 86 [2], pp.158-60. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.idealibrary.com/links/citation/0014-4894/86/158

Gottstein, B. and Bettens, F. (1994): Association between HLA-DR13 and susceptibility to alveolar echinococcosis, J Infect Dis 169 [6], pp.1416-7.

Grandea, A. G., 3rd; Androlewicz, M. J.; Athwal, R. S.; Geraghty, D. E. and Spies, T. (1995): Dependence of peptide binding by MHC class I molecules on their interaction with TAP, Science 270 [5233], pp.105-8.

Grau, G.E. and De Kossodo, S. (1994): Pathophysiology of cerebral malaria. Cerebral malaria: mediators, mechanical obstruction or more?, Parasitology Today 10, pp.408-14.

Grau, G. E.; Fajardo, L. F.; Piguet, P. F.; Allet, B.; Lambert, P. H. and Vassalli, P. (1987): Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria, Science 237 [4819], pp.1210-2.

Grau, G. E. and Modlin, R. L. (1991): Immune mechanisms in bacterial and parasitic diseases: protective immunity versus pathology, Curr Opin Immunol 3 [4], pp.480-5.

Grau, G. E.; Taylor, T. E.; Molyneux, M. E.; Wirima, J. J.; Vassalli, P.; Hommel, M. and Lambert, P. H. (1989): Tumor necrosis factor and disease severity in children with falciparum malaria, N Engl J Med 320 [24], pp.1586-91.

Gravenor, M. B. and Kwiatkowski, D. (1998): An analysis of the temperature effects of fever on the intra-host population dynamics of Plasmodium falciparum, Parasitology 117 [Pt 2], pp.97-105.

Gravenor, M.B.; McLean, A.R. and Kwiatkowski, D. (1995): The regulation of malaria parasitemia: parameter estimated for a population model, Parasitology 110, pp.115-122.

Greenwood, B.; Marsh, K. and Snow, R. (1991): Why do some Africal children develop severe malaria?, Parasitology Today 7, pp.277-281.

Greenwood, B.M. (1987): Asymptomatic malaria - Do they matter?, Parasitology Today 3 [7], pp.206-214.

Greenwood, B.M. (1997): What's new in malaria control?, Ann Trop Med Parasitol 91, pp.523-531.

Greenwood, B. M.; Bradley, A. K.; Greenwood, A. M.; Byass, P.; Jammeh, K.; Marsh, K.; Tulloch, S.; Oldfield, F. S. and Hayes, R. (1987): Mortality and morbidity from malaria among children in a rural area of The Gambia, West Africa, Transactions of the Royal Society of Tropical Medicine and Hygiene 81, pp.478-486.

Greenwood, B. M.; David, P. H.; Otoo-Forbes, L. N.; Allen, S. J.; Alonso, P. L.; Armstrong Schellenberg, J. R.; Byass, P.; Hurwitz, M.; Menon, A. and Snow, R. W. (1995): Mortality and morbidity from malaria after stopping malaria chemoprophylaxis, Trans R Soc Trop Med Hyg 89 [6], pp.629-33..

Greenwood, B. M.; Greenwood, A. M.; Bradley, A. K.; Snow, R. W.; Byass, P.; Hayes, R. J. and N'Jie, A. B. (1988): Comparison of two strategies for control of malaria within a primary health care programme in the Gambia, Lancet 1 [8595], pp.1121-7..

Griffin, T. A.; Nandi, D.; Cruz, M.; Fehling, H. J.; Kaer, L. V.; Monaco, J. J. and Colbert, R. A. (1998): Immunoproteasome assembly: cooperative incorporation of interferon gamma (IFN-gamma)-inducible subunits, J Exp Med 187 [1], pp.97-104. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.jem.org/cgi/content/full/187/1/97

Grove, J.; Daly, A. K.; Bassendine, M. F. and Day, C. P. (1997): Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis, Hepatology 26 [1], pp.143-6..

Gubler, B.; Daniel, S.; Armandola, E. A.; Hammer, J.; Caillat-Zucman, S. and van Endert, P. M. (1998): Substrate selection by transporters associated with antigen processing occurs during peptide binding to TAP, Mol Immunol 35 [8], pp.427-33.

Guerin-Marchand, C.; Druilhe, P.; Galey, B.; Londono, A.; Patarapotikul, J.; Beaudoin, R. L.; Dubeaux, C.; Tartar, A.; Mercereau-Puijalon, O. and Langsley, G. (1987): A liver-stage-specific antigen of Plasmodium falciparum characterized by gene cloning, Nature 329 [6135], pp.164-7.

Gunewardena, D. M.; Carter, R. and Mendis, K. N. (1994): Patterns of acquired anti-malarial immunity in Sri Lanka, Mem Inst Oswaldo Cruz 89 [Suppl 2], pp.63-5.

Gupta, S.; Snow, R. W.; Donnelly, C. and Newbold, C. (1999): Acquired immunity and postnatal clinical protection in childhood cerebral malaria, Proc R Soc Lond B Biol Sci 266 [1414], pp.33-8.

Gupta, S.; Snow, R. W.; Donnelly, C. A.; Marsh, K. and Newbold, C. (1999): Immunity to non-cerebral severe malaria is acquired after one or two infections, Nat Med 5 [3], pp.340-3.

Gupta, S.; Trenholme, K.; Anderson, R.M. and Day, K.P. (1994): Antigenic diversity and the transmission dynamics of Plasmodium falciparum, Science 263, pp.961-963.

Gyllensten, U. B. and Erlich, H. A. (1989): Ancient roots for polymorphism at the HLA-DQ alpha locus in primates, Proc Natl Acad Sci U S A 86 [24], pp.9986-90.

Haldane, J.B.S. (1949): The rate of mutation of human genes, Proceedings of the Eighth International Congress of Genetics and Heredity.

Hamann, A.; Mantzoros, C.; Vidal-Puig, A. and Flier, J. S. (1995): Genetic variability in the TNF-alpha promoter is not associated with type II diabetes mellitus (NIDDM), Biochem Biophys Res Commun 211 [3], pp.833-9.

Harding, C. V. (1997): MHC molecules and antigen processing, 1. ed., Springer, Heidelberg.

Harrison, J. and Ridley, D. S. (1975): Heterologous reactions involving parasites, blood group antibodies and tissue components, Trans R Soc Trop Med Hyg 69 [3], pp.312-7.

Harrison, K. A. (1982): Anaemia, malaria and sickle cell disease, Clin Obstet Gynaecol 9 [3], pp.445-77.

Heard, R. (1994): HLA and autoimmune disease, Lechler, R., Ed, HLA and disease, pp. 131-144, Academic Press Inc., San Diego.

Hebbel, R. P. (1991): Beyond hemoglobin polymerization: the red blood cell membrane and sickle disease pathophysiology, Blood 77 [2], pp.214-37.

Heber-Katz, E.; Hansburg, D. and Schwartz, R. H. (1983): The Ia molecule of the antigen-presenting cell plays a critical role in immune response gene regulation of T cell activation, J Mol Cell Immunol 1 [1], pp.3-18.

Herberg, J. A.; Sgouros, J.; Jones, T.; Copeman, J.; Humphray, S. J.; Sheer, D.; Cresswell, P.; Beck, S. and Trowsdale, J. (1998): Genomic analysis of the Tapasin gene, located close to the TAP loci in the MHC, Eur J Immunol 28 [2], pp.459-67. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.ncbi.nlm.nih.gov/htbin-post/Omim/getmim%3ffield=medline_uid&search=9521053

Hermel, E.; Grigorenko, E. and Lindahl, K. F. (1991): Expression of medial class I histocompatibility antigens on RMA-S mutant cells, Int Immunol 3 [4], pp.407-12.

Herrmann, S. M.; Ricard, S.; Nicaud, V.; Mallet, C.; Arveiler, D.; Evans, A.; Ruidavets, J. B.; Luc, G.; Bara, L.; Parra, H. J.; Poirier, O. and Cambien, F. (1998): Polymorphisms of the tumour necrosis factor-alpha gene, coronary heart disease and obesity, Eur J Clin Invest 28 [1], pp.59-66. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.ncbi.nlm.nih.gov/htbin-post/Omim/getmim%3ffield=medline_uid&search=9502188

Higuchi, T.; Seki, N.; Kamizono, S.; Yamada, A.; Kimura, A.; Kato, H. and Itoh, K. (1998): Polymorphism of the 5'-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese, Tissue Antigens 51 [6], pp.605-12..

Hill, A. V. (1998): The immunogenetics of human infectious diseases, Annu Rev Immunol 16, pp.593-617. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.ncbi.nlm.nih.gov/htbin-post/Omim/getmim%3ffield=medline_uid&search=9597143

Hill, A. V.; Allsopp, C. E.; Kwiatkowski, D.; Anstey, N. M.; Twumasi, P.; Rowe, P. A.; Bennett, S.; Brewster, D.; McMichael, A. J. and Greenwood, B. M. (1991): Common west African HLA antigens are associated with protection from severe malaria, Nature 352 [6336], pp.595-600. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.ncbi.nlm.nih.gov/htbin-post/Omim/getmim%3ffield=medline_uid&search=1865923

Hill, A. V.; Elvin, J.; Willis, A. C.; Aidoo, M.; Allsopp, C. E.; Gotch, F. M.; Gao, X. M.; Takiguchi, M.; Greenwood, B. M.; Townsend, A. R.; McMichael, A. and Whittle, H.C. (1992): Molecular analysis of the association of HLA-B53 and resistance to severe malaria, Nature 360 [6403], pp.434-9.

Hill, A. V.; Jepson, A.; Plebanski, M. and Gilbert, S. C. (1997): Genetic analysis of host-parasite coevolution in human malaria, Philos Trans R Soc Lond B Biol Sci 352 [1359], pp.1317-25.

Hill, R.B.; Cambournac, F.J.C. and Simoes, M.P. (1943): Observations on the course of malaria in children in an endemic region, Am J Trop Med 23, pp.147-162.

Ho, M. and Webster, H. K. (1989): Immunology of human malaria. A cellular perspective, Parasite Immunol 11 [2], pp.105-16.

Hoffman, S.L.; Franke, E.D.; Hollingdale, M.R. and Druilhe, P. (1996): Attacking the infected hepatocyte, Hoffman, S.L., Ed, Malaria vaccine development, pp. 35-76, ASM Press, Washington.

Hoffman, S.L.; Isenbarger, D.; Long, G.W.; Sedegah, M.; Szarfman, A.; Waters, L.; Hollingdale, M.R.; van der Meide, P.H.; Finbloom, D.S. and Ballou, W.R. (1989): Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytes, Science 244, pp.1078-1081.

Hogerzeil, H. V.; Hogewoning, A. A.; van Doorn, J. W.; Wernsdorfer, W. H. and van der Kaay, H. J. (1985): In vitro assessment of sensitivity of Plasmodium falciparum to chloroquine and mefloquine in Ghana, Trans R Soc Trop Med Hyg 79 [6], pp.808-11.

Hogh, B.; Gamage-Mendis, A.; Butcher, G. A.; Thompson, R.; Begtrup, K.; Mendis, C.; Enosse, S. M.; Dgedge, M.; Barreto, J.; Eling, W. and Sinden, R. E. (1998): The differing impact of chloroquine and pyrimethamine/sulfadoxine upon the infectivity of malaria species to the mosquito vector, Am J Trop Med Hyg 58 [2], pp.176-82..

Hollingdale, M. R.; Nardin, E. H.; Tharavanij, S.; Schwartz, A. L. and Nussenzweig, R. S. (1984): Inhibition of entry of Plasmodium falciparum and P. vivax sporozoites into cultured cells; an in vitro assay of protective antibodies, J Immunol 132 [2], pp.909-13.

Hommel, M. and Semoff, S. (1988): Expression and function of erythrocyte-associated surface antigens in malaria, Biol Cell 64 [2], pp.183-203.

Hopkins, L. M.; Bull, P. J.; Gerlach, J. A. and Bull, R. W. (1997): Further characterization of HLA homozygous typing cell lines at the LMP2 polymorphic codon 60 by an ARMS typing method, Hum Immunol 53 [2], pp.183-7.

Horwitz, J. P.; Chua, J.; Noel, M.; Donatti, J. T. and Freisler, J. (1966): Substrates for cytochemical demonstration of enzyme activity. II. Some dihalo-3-indolyl phosphates and sulfates, J Med Chem 9 [3], p.447.

Hosken, N. A. and Bevan, M. J. (1992): An endogenous antigenic peptide bypasses the class I antigen presentation defect in RMA-S, J Exp Med 175 [3], pp.719-29.

Howard, J.; Carlton, J. M.; Walliker, D. and Jensen, J. B. (1996): Use of random amplified polymorphic DNA (RAPD) technique in inheritance studies of Plasmodium falciparum, J Parasitol 82 [6], pp.941-6.

Hughes, A. L. and Nei, M. (1988): Pattern of nucleotide substitution at major histocompatibility complex class I loci reveals overdominant selection, Nature 335 [6186], pp.167-70.

Hughes, A. L. and Nei, M. (1989): Nucleotide substitution at major histocompatibility complex class II loci: evidence for overdominant selection, Proc Natl Acad Sci U S A 86 [3], pp.958-62.

Hurley, C. K. (1993): HLA diversity in African Americans, Transplant Proc 25 [4],p.2399.

Hyde, J. E. (1990): The dihydrofolate reductase-thymidylate synthetase gene in the drug resistance of malaria parasites, Pharmacol Ther 48 [1], pp.45-59.

Innis, M.A.; Gelfand, D.H.; Snisky, I.J. and White, T.J. (1990): PCR Protocols. A guide to methods and applications, Academic Press, Inc., San Diego, New York.

Ismail, A.; Bousaffara, R.; Kaziz, J.; Zili, J.; el Kamel, A.; Tahar Sfar, M.; Remadi, S. and Chouchane, L. (1997): Polymorphism in transporter antigen peptides gene (TAP1) associated with atopy in Tunisians, J Allergy Clin Immunol 99 [2], pp.216-23.

Jacobs, P.; Radzioch, D. and Stevenson, M. M. (1995): Nitric oxide expression in the spleen, but not in the liver, correlates with resistance to blood-stage malaria in mice, J Immunol 155 [11], pp.5306-13.

James, S.P. and ... (1931): Some general results of a study of induced malaria in England, Trans R Soc Trop Med Hyg 24, pp.477-525.

Jarra, W. and Snounou, G. (1998): Only viable parasites are detected by PCR following clearance of rodent malarial infections by drug treatment or immune responses, Infect Immun 66 [8], pp.3783-3787.

Jeffery, G.M. (1966): Epidemiological significance of repeated infections with homologous and heterologous strains and species of Plasmodium, Bull WHO 35, pp.873-882.

Jepson, A.; Sisay-Joof, F.; Banya, W.; Hassan-King, M.; Frodsham, A.; Bennett, S.; Hill, A.V.S. and Whittle, H. (1997): Genetic linkage of mild malaria to the major histocompatibility complex in Gambian children: study of affected sibling pairs, British Medical Journal 315, pp.96-97.

Jepson, A. P.; Banya, W. A.; Sisay-Joof, F.; Hassan-King, M.; Bennett, S. and Whittle, H. C. (1995): Genetic regulation of fever in Plasmodium falciparum malaria in Gambian twin children, J Infect Dis 172 [1], pp.316-9.

Johnson, R. A.; Waddelow, T. A.; Caro, J.; Oliff, A. and Roodman, G. D. (1989): Chronic exposure to tumor necrosis factor in vivo preferentially inhibits erythropoiesis in nude mice, Blood 74 [1], pp.130-8.

Jongeneel, C.V.; Braint, L.; Udalova, I.A.; Sevin, A.; Nedospasov, S.A. and Cabon-Thomsen, A. (1991): Extensive genetic polymorphism in the human tumor necrosis factor region and relation to extended HLA haplotypes, Proc Natl Acad Sci USA 88, pp.9717-.

Joshi, S. K.; Bharadwaj, A.; Chatterjee, S. and Chauhan, V. S. (2000): Analysis of immune responses against T- and B-cell epitopes from Plasmodium falciparum liver-stage antigen 1 in rodent malaria models and malaria-exposed human subjects in India, Infect Immun 68 [1], pp.141-50.. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://iai.asm.org/cgi/content/abstract/68/1/141

Kamol-Ratanakul, P.; Chirakalwasarn, N.; Lertmaharit, S.; Dhanamun, B.; Seublinwong, T.; Udomsangpetch, R.; Perlmann, H. and Thaithong, S. (1992): Seroepidemiological studies of humoral response to the Plasmodium falciparum antigens in Thailand, Am J Trop Med Hyg 47, pp.554-561.

Kappes, D. and Strominger, J. L. (1988): Human class II major histocompatibility complex genes and proteins, Annu Rev Biochem 57, pp.991-1028.

Kappler, J. W.; Roehm, N. and Marrack, P. (1987): T cell tolerance by clonal elimination in the thymus, Cell 49 [2], pp.273-80.

Karunaweera, N. D.; Grau, G. E.; Gamage, P.; Carter, R. and Mendis, K. N. (1992): Dynamics of fever and serum levels of tumor necrosis factor are closely associated during clinical paroxysms in Plasmodium vivax malaria, Proc Natl Acad Sci U S A 89 [8], pp.3200-3.

Kaslow, D. C. (1998): Acquired immunity to sexual stages, Sherman, I. W., Ed, Malaria - parasite biology, pathogenesis, and protection, 1. ed., pp. 457-466, ASM Press, Washington.

Kaufman, J. F.; Auffray, C.; Korman, A. J.; Shackelford, D. A. and Strominger, J. (1984): The class II molecules of the human and murine major histocompatibility complex, Cell 36 [1], pp.1-13.

Kelly, A. P.; Monaco, J. J.; Cho, S. G. and Trowsdale, J. (1991): A new human HLA class II-related locus, DM, Nature 353 [6344], pp.571-3. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.ncbi.nlm.nih.gov/htbin-post/Omim/getmim%3ffield=medline_uid&search=1922365

Kemp, D. J. (1992): Antigenic diversity and variation in blood stages of Plasmodium falciparum, Immunol Cell Biol 70 [Pt 3], pp.201-7.

Kern, P.; Hemmer, C. J.; Van Damme, J.; Gruss, H. J. and Dietrich, M. (1989): Elevated tumor necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria, Am J Med 87 [2], pp.139-43.

Kimura, A. and Sazazuki, T. (1992): XI. International Histocompatibility Workshop reference protocol for the HLA DNA typing technique, 1992, Tsuij, K.; Aizawa, M. and Sazazuki, T., Eds, HLA 1991, Proceedings of the XI. International Histocompatibility Workshop and Conference, pp. 397-419, Oxford University Press, Oxford, UK.

Kimura, E.; Mattei, D.; di Santi, S. M. and Scherf, A. (1990): Genetic diversity in the major merozoite surface antigen of Plasmodium falciparum: high prevalence of a third polymorphic form detected in strains derived from malaria patients, Gene 91 [1], pp.57-62.

Kimura, M. (1983): Rare variant alleles in the light of the neutral theory, Mol Biol Evol 1 [1], pp.84-93..

Kirkman, L. A.; Su, X. Z. and Wellems, T. E. (1996): Plasmodium falciparum: isolation of large numbers of parasite clones from infected blood samples, Exp Parasitol 83 [1], pp.147-9. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.idealibrary.com/links/citation/0014-4894/83/147

Kitagawa, S.; Yuo, A.; Yagisawa, M.; Azuma, E.; Yoshida, M.; Furukawa, Y.; Takahashi, M.; Masuyama, J. and Takaku, F. (1996): Activation of human monocyte functions by tumor necrosis factor: rapid priming for enhanced release of superoxide and erythrophagocytosis, but no direct triggering of superoxide release, Exp Hematol 24 [4], pp.559-67.

Kitua, A.Y.; Smith, T.A.; Alonso, P.L.; Urassa, H.; Masanja, H.; Kimario, J. and Tanner, M. (1997): The role of low level Plasmodium falciparum parasitaemia in anaemia among infants living in an area of intense and perennial transmission, Tropical Medicine and International Health 2 [4], pp.325-333.

Klein, J. (1980): Generation of diversity at MHC loci: Implications for T-cell receptor repertoires, Fongereau, M. and Dausset, J., Eds, Immunology, pp. 239-153, ••, ••.

Klein, J. (1986): Natural history of the major histocompatibility complex, John Wiley & Sons Inc., New York, NY.

Klein, J. (1987): Origin of major histocompatibility complex polymorphism: the trans- species hypothesis, Hum Immunol 19 [3], pp.155-62.

Klein, J. (1991): Of HLA, tryps, and selection: an essay on coevolution of MHC and parasites, Hum Immunol 30 [4], pp.247-58.

Klein, J. and Figueroa, F. (1986): Evolution of the major histocompatibility complex, Crit Rev Immunol 6, pp.295-386.

Klein, J. and O'Huigin, C. (1994): MHC polymorphism and parasites, Philos Trans R Soc Lond B Biol Sci 346 [1317], pp.351-7; discussion 357-8.

Klein, J.; O'HUigin, C.; Figueroa, F.; Mayer, W. E. and Klein, D. (1993): Different modes of Mhc evolution in primates, Mol Biol Evol 10 [1], pp.48-59.

Knight, J. C. and Kwiatkowski, D. (1999): Inherited variability of tumor necrosis factor production and susceptibility to infectious disease, Proc Assoc Am Physicians 111 [4], pp.290-8.

Knight, J. C.; Udalova, I.; Hill, A. V.; Greenwood, B. M.; Peshu, N.; Marsh, K. and Kwiatkowski, D. (1999): A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria, Nat Genet 22 [2], pp.145-50.

Knowles, R.; White, R.S. and Das Gupta, B.M. (1930): Studies in the parasitology of malaria, Indian medical research memoires 18, pp.1-436.

Koram, K.A.; Bennett, S.; Adiamah, J.H. and Greenwood, B.M. (1995): Socio-economic determinants are not major risk factors for severe malaria in Gambian children, Transactions of the Royal Society of Tropical Medicine and Hygiene 89, pp.151-154.

Korman, A. J.; Boss, J. M.; Spies, T.; Sorrentino, R.; Okada, K. and Strominger, J. L. (1985): Genetic complexity and expression of human class II histocompatibility antigens, Immunol Rev 85, pp.45-86.

Korman, A. J.; Boss, J. M.; Spies, T.; Sorrentino, R.; Okada, K. and Strominger, J. L. (1985): Genetic complexity and expression of human class II histocompatibility antigens, Immunol Rev 85, pp.45-86.

Kremsner, P. G.; Neifer, S.; Chaves, M. F.; Rudolph, R. and Bienzle, U. (1992): Interferon-gamma induced lethality in the late phase of Plasmodium vinckei malaria despite effective parasite clearance by chloroquine, Eur J Immunol 22 [11], pp.2873-8.

Kremsner, P. G.; Radloff, P.; Metzger, W.; Wildling, E.; Mordmuller, B.; Philipps, J.; Jenne, L.; Nkeyi, M.; Prada, J.; Bienzle, U. and et al. (1995): Quinine plus clindamycin improves chemotherapy of severe malaria in children, Antimicrob Agents Chemother 39 [7], pp.1603-5.

Kremsner, P. G.; Winkler, S.; Brandts, C.; Neifer, S.; Bienzle, U. and Graninger, W. (1994): Clindamycin in combination with chloroquine or quinine is an effective therapy for uncomplicated Plasmodium falciparum malaria in children from Gabon, J Infect Dis 169 [2], pp.467-70..

Kremsner, P. G.; Winkler, S.; Brandts, C.; Wildling, E.; Jenne, L.; Graninger, W.; Prada, J.; Bienzle, U.; Juillard, P. and Grau, G. E. (1995): Prediction of accelerated cure in Plasmodium falciparum malaria by the elevated capacity of tumor necrosis factor production, Am J Trop Med Hyg 53 [5], pp.532-8.

Kremsner, P. G.; Winkler, S.; Wildling, E.; Prada, J.; Bienzle, U.; Graninger, W. and Nussler, A. K. (1996): High plasma levels of nitrogen oxides are associated with severe disease and correlate with rapid parasitological and clinical cure in Plasmodium falciparum malaria, Trans R Soc Trop Med Hyg 90 [1], pp.44-7.

Krogstad, D.J. and De, D. (1998): Chloroquine: modes of action and resistance and the activity of chloroquine analogs, Sherman, I.W., Ed, Malaria: Parasite biology, pathogenesis, and protection, pp. 331-340, ASM Press, Washington, D.C..

Krogstad, D. J.; Gluzman, I. Y.; Herwaldt, B. L.; Schlesinger, P. H. and Wellems, T. E. (1992): Energy dependence of chloroquine accumulation and chloroquine efflux in Plasmodium falciparum, Biochem Pharmacol 43 [1], pp.57-62..

Krogstad, D. J.; Schlesinger, P. H. and Gluzman, I. Y. (1985): Antimalarials increase vesicle pH in Plasmodium falciparum, J Cell Biol 101 [6], pp.2302-9..

Krzych, U.; Lyon, J. A.; Jareed, T.; Schneider, I.; Hollingdale, M. R.; Gordon, D. M. and Ballou, W. R. (1995): T lymphocytes from volunteers immunized with irradiated Plasmodium falciparum sporozoites recognize liver and blood stage malaria antigens, J Immunol 155 [8], pp.4072-7..

Kun, J.; Mordmüller, B.; Perkins, D.J.; Lell, B.; May, J.; Mercereau-Puijalon, O.; Alpers, M.; Weinberg, B. and Kremsner, P.G. (zur Veröffentlichung eingereicht): NOSLambarene mutation and NO production in malaria patients.

Kun, J. F.; Lehman, L. G.; Lell, B.; Schmidt-Ott, R. and Kremsner, P. G. (1999): Low-dose treatment with sulfadoxine-pyrimethamine combinations selects for drug-resistant Plasmodium falciparum strains, Antimicrob Agents Chemother 43 [9], pp.2205-8.. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://aac.asm.org/cgi/content/abstract/43/9/2205

Kun, J. F.; Mordmuller, B.; Lell, B.; Lehman, L. G.; Luckner, D. and Kremsner, P. G. (1998): Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against malaria, Lancet 351 [9098], pp.265-6.

Kun, J.F.J.; Klabunde, J.; Lell, B.; Luckner, D.; Alpers, M.; May, J.; Meyer, C.G. and Kremsner, P.G. (1999): The ICAM-1Kilifi mutation is associated with protection against severe malaria in Lambaréné, Gabon, Am J Trop Med Hyg 61, pp.776-779.

Kun, J.F.J.; Schmidt-Ott, R.J.; Lehman, L.G.; Lell, B.; Luckner, D.; Greve, B.; Matousek, P. and Kremsner, P.G. (1998): Merozoite surface antigen 1 and 2 genotypes and rosetting of Plasmodium falciparum in severe and mild malaria in Lambaréné, Gabon, Trans R Soc Trop Med Hyg 92, pp.110-114.

Kurdi-Haidar, B. and Luzzatto, L. (1990): Expression and characterization of glucose-6-phosphate dehydrogenase of Plasmodium falciparum, Mol Biochem Parasitol 41 [1], pp.83-91.

Kurtis, J. D.; Lanar, D. E.; Opollo, M. and Duffy, P. E. (1999): Interleukin-10 responses to liver-stage antigen 1 predict human resistance to Plasmodium falciparum, Infect Immun 67 [7], pp.3424-9. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://iai.asm.org/cgi/content/full/67/7/3424

Kurtzhals, J. A.; Adabayeri, V.; Goka, B. Q.; Akanmori, B. D.; Oliver-Commey, J. O.; Nkrumah, F. K.; Behr, C. and Hviid, L. (1998): Low plasma concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria, Lancet 351 [9118], pp.1768-72.

Kwiatkowski, D. (2000): Genetic susceptibility to malaria getting complex, Curr Opin Genet Dev 10 [3], pp.320-4. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.biomednet.com/article/gda313

Kwiatkowski, D.; Cannon, J. G.; Manogue, K. R.; Cerami, A.; Dinarello, C. A. and Greenwood, B. M. (1989a): Tumour necrosis factor production in Falciparum malaria and its association with schizont rupture, Clin Exp Immunol 77 [3], pp.361-366.

Kwiatkowski, D. and Greenwood, B. M. (1989b): Why is malaria fever periodic?, Parasitology Today 5, pp.264-266.

Kwiatkowski, D.; Hill, A. V.; Sambou, I.; Twumasi, P.; Castracane, J.; Manogue, K. R.; Cerami, A.; Brewster, D. R. and Greenwood, B. M. (1990): TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria, Lancet 336 [8725], pp.1201-4.

Kwiatkowski, D.; Molyneux, M. E.; Stephens, S.; Curtis, N.; Klein, N.; Pointaire, P.; Smit, M.; Allan, R.; Brewster, D. R.; Grau, G. E. and et al. (1993): Anti-TNF therapy inhibits fever in cerebral malaria, Q J Med 86 [2], pp.91-8.

Kwiatkowski, D. and Perlmann, P. (1999): Inflammatory processes in the pathogenesis of malaria, Wahlgren, M. and Perlmann, P., Eds, Malaria - molecular and clinical aspects, Harwood Academic Publishers, Amsterdam.

Kwok, W. W.; Schwarz, D.; Nepom, B. S.; Hock, R. A.; Thurtle, P. S. and Nepom, G. T. (1988): HLA-DQ molecules form alpha-beta heterodimers of mixed allotype, J Immunol 141 [9], pp.3123-7.

Kyes, S.; Harding, R.; Black, G.; Craig, A.; Peshu, N.; Newbold, C. and Marsh, K. (1997): Limited spatial clustering of individual Plasmodium falciparum alleles in field isolates from coastal Kenya, Am J Trop Med Hyg 57 [2], pp.205-15.

Lalvani, A. and Hill, A. V. (1998): Cytotoxic T-lymphocytes against malaria and tuberculosis: from natural immunity to vaccine design, Clin Sci (Colch) 95 [5], pp.531-8. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://cs.portlandpress.co.uk/cs/095/0531/cs0950531.htm

Lalvani, A.; Hurt, N.; Aidoo, M.; Kibatala, P.; Tanner, M. and Hill, A. V. (1996): Cytotoxic T lymphocytes to Plasmodium falciparum epitopes in an area of intense and perennial transmission in Tanzania, Eur J Immunol 26 [4], pp.773-9.

Lander, E. S. and Schork, N. J. (1994): Genetic dissection of complex traits, Science 265 [5181], pp.2037-48.

Landgraf, B.; Kollaritsch, H.; Wiedermann, G. and Wernsdorfer, W. H. (1994): Plasmodium falciparum: susceptibility in vitro and in vivo to chloroquine and sulfadoxine-pyrimethamine in Ghanaian schoolchildren, Trans R Soc Trop Med Hyg 88 [4], pp.440-2..

Le Moine, O.; Louis, H.; Sermon, F.; Goldman, M. and Deviere, J. (1999): Interleukin-10 and liver diseases, Acta Gastroenterol Belg 62 [1], pp.1-8.

Lehner, P. J.; Surman, M. J. and Cresswell, P. (1998): Soluble tapasin restores MHC class I expression and function in the tapasin-negative cell line .220, Immunity 8 [2], pp.221-31. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.immunity.com/cgi/content/full/8/2/221

Lell, B.; May, J.; Schmidt-Ott, R.; Lehmann, L.G.; Kuckner, D.; Greve, B.; Matousek, P.; Schmid, D.; Herbich, K.; Meyer, C.G.; Bienzle, U. and Kremsner, P.G. (1999): The role of red blood cell polymorphisms in resistance and suscebility to malaria, Clin Infect Dis 28, pp.794-799.

Levesque, M. C.; Hobbs, M. R.; Anstey, N. M.; Vaughn, T. N.; Chancellor, J. A.; Pole, A.; Perkins, D. J.; Misukonis, M. A.; Chanock, S. J.; Granger, D. L. and Weinberg, J. B. (1999): Nitric oxide synthase type 2 promoter polymorphisms, nitric oxide production, and disease severity in Tanzanian children with malaria, J Infect Dis 180 [6], pp.1994-2002. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.journals.uchicago.edu/cgi-bin/resolve%3fJID990457ABS

Li, S.; Sjogren, H. O.; Hellman, U.; Pettersson, R. F. and Wang, P. (1997): Cloning and functional characterization of a subunit of the transporter associated with antigen processing, Proc Natl Acad Sci U S A 94 [16], pp.8708-13. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.pnas.org/cgi/content/full/94/16/8708

Lim, J.K.; Hunter, J.; Fernandez-Viña, M. and Mann, D.L. (1999): Characterization of LMP polymorphism in homozygous typing cells and a random population, Hum Immunol 60, pp.145-151.

Looareesuwan, S.; Merry, A. H.; Phillips, R. E.; Pleehachinda, R.; Wattanagoon, Y.; Ho, M.; Charoenlarp, P.; Warrell, D. A. and Weatherall, D. J. (1987b): Reduced erythrocyte survival following clearance of malarial parasitaemia in Thai patients, Br J Haematol 67 [4], pp.473-8.

Looareesuwan, S.; White, N. J.; Chittamas, S.; Bunnag, D. and Harinasuta, T. (1987a): High rate of Plasmodium vivax relapse following treatment of falciparum malaria in Thailand, Lancet 2 [8567], pp.1052-5.

Looareesuwan, S.; Wilairatana, P.; Vanijanonta, S.; Pitisuttithum, P.; Ratanapong, Y. and Andrial, M. (1997): Monotherapy with sodium artesunate for uncomplicated falciparum malaria in Thailand: a comparison of 5- and 7-day regimens, Acta Trop 67 [3], pp.197-205..

Lotteau, V.; Teyton, L.; Burroughs, D. and Charron, D. (1987): A novel HLA class II molecule (DR alpha-DQ beta) created by mismatched isotype pairing, Nature 329 [6137], pp.339-41.

Luckner, D.; Lell, B.; Greve, B.; Lehman, L. G.; Schmidt-Ott, R. J.; Matousek, P.; Herbich, K.; Schmid, D.; Mba, R. and Kremsner, P. G. (1998): No influence of socioeconomic factors on severe malarial anaemia, hyperparasitaemia or reinfection, Trans R Soc Trop Med Hyg 92 [5], pp.478-81.

Lundin, K. E.; Gaudernack, G.; Qvigstad, E.; Sollid, L. M. and Thorsby, E. (1988): T lymphocyte clones recognizing an HLA-DQw3.2-associated epitope involving residue 57 on the DQ beta chain, Hum Immunol 22 [4], pp.235-46.

Luty, AFJ; Perkins, DJ and ... (submitted): Low IL-12 activity in severe Plasmodium falciparum malaria.

Luty, A. J.; Lell, B.; Schmidt-Ott, R.; Lehman, L. G.; Luckner, D.; Greve, B.; Matousek, P.; Herbich, K.; Schmid, D.; Migot-Nabias, F.; Deloron, P.; Nussenzweig, R. S. and Kremsner, P. G. (1999): Interferon-g responses are associated with resistance to reinfection with Plasmodium falciparum in young African children, J Infect Dis 179 [4], pp.980-8.

Luty, A. J.; Lell, B.; Schmidt-Ott, R.; Lehman, L. G.; Luckner, D.; Greve, B.; Matousek, P.; Herbich, K.; Schmid, D.; Ulbert, S.; Migot-Nabias, F.; Dubois, B.; Deloron, P. and Kremsner, P. G. (1998): Parasite antigen-specific interleukin-10 and antibody reponses predict accelerated parasite clearance in Plasmodium falciparum malaria, Eur Cytokine Netw 9 [4], pp.639-46. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.john-libbey-eurotext.fr/en/revues/ecn/aC8796B76.htm

Luzzatto, L. (1979): Genetics of red cells and susceptibility to malaria, Blood 54 [5], pp.961-76.

Luzzatto, L. and Allan, N.C. (1968): Relationship between the genes for glucose-6-phosphate dehydrogenase and for haemoglobin in a Nigerian population, Nature 219, pp.1041-1042.

Luzzatto, L. and Mehta, A. (1995): The metabolic and molecular basis of inherited disease, Scriver, Ed, Glucose-6-Phosphate Dehydrogenase Deficiency, 7.. ed., pp. 3367-3398.

Luzzatto, L.; Nwachuku-Jarrett, E. S. and Reddy, S. (1970): Increased sickling of parasitised erythrocytes as mechanism of resistance against malaria in the sickle-cell trait, Lancet 1 [7642], pp.319-21.

Luzzatto, L.; Usanga, F. A. and Reddy, S. (1969): Glucose-6-phosphate dehydrogenase deficient red cells: resistance to infection by malarial parasites, Science 164 [881], pp.839-42. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.ncbi.nlm.nih.gov/htbin-post/Omim/getmim%3ffield=medline_uid&search=4889647

Mabey, D. C.; Brown, A. and Greenwood, B. M. (1987): Plasmodium falciparum malaria and Salmonella infections in Gambian children, J Infect Dis 155 [6], pp.1319-21.

Mack, D. G.; Johnson, J. J.; Roberts, F.; Roberts, C. W.; Estes, R. G.; David, C.; Grumet, F. C. and McLeod, R. (1999): HLA-class II genes modify outcome of Toxoplasma gondii infection, Int J Parasitol 29 [9], pp.1351-8.

MacPherson, G. G.; Warrell, M. J.; White, N. J.; Looareesuwan, S. and Warrell, D. A. (1985): Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration, Am J Pathol 119 [3], pp.385-401.

Maitland, K.; Williams, T.; Bennett, S.; Newbold, C.I.; Peto, T.E.A.; Viji, J.; Timothy, R.; Clegg, J.B.; Weatherall, D.J. and Bowden, D.K. (1996): The interaction between Plasmodium falciparum and P. vivax in children on Espiritu Santo island, Vanuatu, Transactions of the Royal Society of Tropical Medicine and Hygiene 90, pp.614-620.

Maitland, K.A.; Williams, T.N. and Newbold, C.I. (1997): Plasmodium vivax and P. falciparum: Biological interactions and the possibilty of cross-species immunity, Parasitology Today 13 [6], pp.227-231.

Marsh, K. (1992): Malaria - a neglected disease?, Parasitology 104, pp.S53-S66.

Marsh, K. (1999): Clinical features of malaria, Wahlgren, M. and Perlmann, P., Eds, Malaria - molecular and clinical aspects, Harwood Academic Publishers, Amsterdam.

Marsh, K.; Ortoo, L.; Hayes, R.J.; Carson, D.C. and Greenwood, B.M. (1989): Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection, Trans R Soc Trop Med Hyg 83, pp.293-303.

Marshall, V. M.; Zhang, L.; Anders, R. F. and Coppel, R. L. (1996): Diversity of the vaccine candidate AMA-1 of Plasmodium falciparum, Mol Biochem Parasitol 77 [1], pp.109-13.

Martin, S.K.; Miller, L.H. and Alling, D. (1979): Severe malaria and glucose-6-phosphate deficiency: A reappraisal of the malaria/G6PD hypothesis, Lancet i, pp.524-526.

Masawe, A.E. (1981): Nutritional anaemias. Part 1: Tropical Africa., Clin Haematol 10 [3], pp.815-42.

Mattiuz, P.L.; Ihde, D.; Piazza, A.; Ceppelini, R. and Bodmer, W.D. (1970): New approaches to the population genetic and segregation analysis of the HLA system, Terasaki, P., Ed, Histocompatibility testing, Mungsgaard, Copenhagen.

May, J. (1995): Assoziation von MHC-DPA1-Allelen mit den Manifestationsformen der Onchocerca-volvulus-Infektion bei Westrafrikanern aus einem Hyperendemiegebiet, Institut für Tropenmedizin: Freie Universität Berlin Berlin.

May, J.; Burchard, G.; Bienzle, U.; Kremsner, P.G. and Meyer, C.G. (submitted): "G6PD silent mutation".

May, J.; Falusi, A.G.; Ademowo, O.G.; Olumese, P.E.; Großterlinden, L.; Mockenhaupt, F.P.; Meyer, C.G.; Luzzatto, L. and Bienzle, U. (2000b): Red cell glucose-6-phosphat dehydrogenase status and pyruvat kinase activity in a Nigerian population, Trop Med Int Health 5, pp.119-123.

May, J.; Falusi, A.G.; Mockenhaupt, F.; Ademowo, P.O.; Olumese, P.; Bienzle, U. and Meyer, C.G. (2000a): Impact of subpatent multi-species and multi-clonal plasmodial infections on anaemia in children from Nigeria, Trans R Soc Trop Med Hyg 94, pp.399-403.

May, J.; Kremsner, P. G.; Milovanovic, D.; Schnittger, L.; Loliger, C. C.; Bienzle, U. and Meyer, C. G. (1998b): HLA-DP control of human Schistosoma haematobium infection, Am J Trop Med Hyg 59 [2], pp.302-6.

May, J.; Kretschmer, C.; Schnittger, L.; Striecker, R.; Kremsner, P. G. and Meyer, C. G. (1996): DPA1*0105, a novel DPA1 variant in a negroid population, Tissue Antigens 48 [5], pp.593-4.

May, J.; Lell, B.; Luty, A.; Meyer, C.G. and Kremsner, P.G. (2000c): Plasma Interleukin 10:Tumor necrosis factor (TNF) ratio is associated with TNF promoter variants and predicts malarial complications, Journal of Infectious Diseases 182, pp.1570-1573.

May, J.; Lell, B.; Luty, A.J.F.; Meyer, C.G. and Kremsner, P.G. (2001): HLA-DQB1*0501-restricted Th1-type immune responses to a Plasmodium falciparum liver stage antigen protect from anaemia in malarial infection, Journal of Infectious Diseases 183, pp.168-172.

May, J.; Meyer, C. G.; Kun, J. F.; Lell, B.; Luckner, D.; Dippmann, A. K.; Bienzle, U. and Kremsner, P. G. (1999b): HLA class II factors associated with Plasmodium falciparum merozoite surface antigen allele families, J Infect Dis 179 [4], pp.1042-5.

May, J.; Mockenhaupt, F. P.; Ademowo, O. G.; Falusi, A. G.; Olumese, P. E.; Bienzle, U. and Meyer, C. G. (1999a): High rate of mixed and subpatent malarial infections in southwest Nigeria, Am J Trop Med Hyg 61 [2], pp.339-343.

May, J.; Mockenhaupt, F. P.; Loliger, C. C.; Ademowo, G. O.; Falusi, A. G.; Jenisch, S.; Dippmann, K.; Schnittger, L.; Kremsner, P. G.; Bienzle, U. and Meyer, C. G. (1998a): HLA DPA1/DPB1 genotype and haplotype frequencies, and linkage disequilibria in Nigeria, Liberia, and Gabon, Tissue Antigens 52 [3], pp.199-207.

Mayor, A. G.; Gomez-Olive, X.; Aponte, J. J.; Casimiro, S.; Mabunda, S.; Dgedge, M.; Barreto, A. and Alonso, P. L. (2001): Prevalence of the K76T Mutation in the Putative Plasmodium falciparum Chloroquine Resistance Transporter (pfcrt) Gene and Its Relation to Chloroquine Resistance in Mozambique, J Infect Dis 183 [9], pp.1413-6..

McCutcheon, K. R.; Freese, J. A.; Frean, J. A.; Veale, R. B.; Sharp, B. L. and Markus, M. B. (2000): Chloroquine-resistant isolates of Plasmodium falciparum with alternative CG2 omega repeat length polymorphisms, Am J Trop Med Hyg 62 [2], pp.190-2.

McGregor, I.A. (1986): The development and maintenace of immunity of malaria in highly endemic areas, Clinics in Tropical Medicine and Communicable Diseases 1, pp.29-53.

McGregor, I.A.; Billiwicz, W.Z. and Thomson, A.M. (1961): Growth and mortality in children in an African village, British Medical Journal ii, pp.1661-166?.

McGregor, I. A. and Wilson, R. J. M. (1988): Specific immunity: acquired in man, Wernsdorfer, W. H. and McGregor, I. A., Eds, Malaria, principles and practices of malariology, pp. 559-619, Churchill Livingston Inc., New York, N. Y..

McGuire, W.; Hill, A. V.; Allsopp, C. E.; Greenwood, B. M. and Kwiatkowski, D. (1994): Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria, Nature 371 [6497], pp.508-10. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.ncbi.nlm.nih.gov/htbin-post/Omim/getmim%3ffield=medline_uid&search=7935762

McGuire, W.; Knight, J. C.; Hill, A. V.; Allsopp, C. E.; Greenwood, B. M. and Kwiatkowski, D. (1999): Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles, J Infect Dis 179 [1], pp.287-90. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.journals.uchicago.edu/cgi-bin/resolve%3fJID971441ABS

Mellouk, S.; Green, S. J.; Nacy, C. A. and Hoffman, S. L. (1991): IFN-gamma inhibits development of Plasmodium berghei exoerythrocytic stages in hepatocytes by an L-arginine-dependent effector mechanism, J Immunol 146 [11], pp.3971-6.

Mellouk, S.; Mazier, D.; Druilhe, P.; Berbiguier, N. and Danis, M. (1986): In vitro and in vivo results suggesting that anti-sporozoite antibodies do not totally block Plasmodium falciparum sporozoite infectivity, N Engl J Med 315 [10], p.648.

Menendez, C.; Kahigwa, E.; Hirt, R.; Vounatsou, P.; Aponte, J. J.; Font, F.; Acosta, C. J.; Schellenberg, D. M.; Galindo, C. M.; Kimario, J.; Urassa, H.; Brabin, B.; Smith, T. A.; Kitua, A. Y.; Tanner, M. and Alonso, P. L. (1997): Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants, Lancet 350 [9081], pp.844-50..

Merry, A. H.; Looareesuwan, S.; Phillips, R. E.; Chanthavanich, P.; Supanaranond, W.; Warrell, D. A. and Weatherall, D. J. (1986): Evidence against immune haemolysis in falciparum malaria in Thailand, Br J Haematol 64 [1], pp.187-94.

Metzger, W.G.; Mordmüller, B.G. and Kremsner, P.G. (1995): Malaria pigment in leucocytes, Trans R Soc Trop Med Hyg 89, pp.637-638.

Meyer, C. G.; Gallin, M.; Erttmann, K. D.; Brattig, N.; Schnittger, L.; Gelhaus, A.; Tannich, E.; Begovich, A. B.; Erlich, H. A. and Horstmann, R. D. (1994): HLA-D alleles associated with generalized disease, localized disease, and putative immunity in Onchocerca volvulus infection, Proc Natl Acad Sci U S A 91 [16], pp.7515-9. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.ncbi.nlm.nih.gov/htbin-post/Omim/getmim%3ffield=medline_uid&search=8052611

Meyer, C. G.; May, J. and Schnittger, L. (1997): HLA-DP--part of the concert, Immunol Today 18 [2], pp.58-61.

Meyer, C. G.; May, J.; Simon, C.; Bohm, B. O. and Loeliger, C. C. (1996): DPB1*TF, a novel HLA class II DPB1 allele (DPB1*6701) identified in a Turkish family, Tissue Antigens 48 [3], pp.231-2.

Meyer, C. G.; May, J.; Spauke, D. and Schnittger, L. (1994): DPA1*02012: a DPA1*0201-related Mhc class II allele in west Africa, Immunogenetics 40 [4], p.309.

Meyer, C. G.; May, J. and Stark, K. (1998): Human leukocyte antigens in tuberculosis and leprosy, Trends Microbiol 6 [4], pp.148-54. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.biomednet.com/library/fulltext/pii.S0966842X98012402

Meyer, C. G. and Schnittger, L. (1993): A silent mutation in HLA-DPB1*0101 and its evolutionary implications, Hum Immunol 38 [2], pp.123-6.

Meyer, C. G.; Schnittger, L. and May, J. (1996): Met-11 of HLA class II DP alpha 1 first domain associated with onchocerciasis, Exp Clin Immunogenet 13 [1], pp.12-9.

Meyer, C.G.; Spauke, D.; May, J. and Schnittger, L. (1994): Human MHC class II DPB1*02011 and related alleles in West Africa, Mitt Österr Ges Tropenmed Parasitol 16, pp.43-50.

Michal, G. (1983), Bergheimer, U., Ed, Methods of Enzymatic Analysis, 3. ed., pp. 197-232.

Milhous, W.K. and Kyle, D.E. (1998): Introduction to the modes of action of and mechanisms of resistance to antimalarials, Sherman, I.W., Ed, Malaria - parasite biology, pathogenesis, and protection, 1. ed., pp. 303-316, ASM Press, Washington.

Milhous, W.K. and Kyle, D.E. (1998): Introduction to the modes of action and mechanisms of resistance to antimalarials, Sherman, I.W., Ed, Malaria: Parasite biology, pathogenesis, and protection, pp. 303-316, ASM Press, Washington, D.C..

Miller, J.; Golenser, J.; Spira, D. T. and Kosower, N. S. (1984): Plasmodium falciparum: thiol status and growth in normal and glucose-6- phosphate dehydrogenase deficient human erythrocytes, Exp Parasitol 57 [3], pp.239-47.

Miller, L. H.; Good, M. F. and Kaslow, D. C. (1998): Vaccines against the blood stages of falciparum malaria, Adv Exp Med Biol 452, pp.193-205.

Miller, L. H.; Mason, S. J.; Dvorak, J. A.; McGinniss, M. H. and Rothman, I. K. (1975): Erythrocyte receptors for (Plasmodium knowlesi) malaria: Duffy blood group determinants, Science 189 [4202], pp.561-3. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.ncbi.nlm.nih.gov/htbin-post/Omim/getmim%3ffield=medline_uid&search=1145213

Miller, R.L.; Ikram, S.; Armelagos, G.J.; Walker, R.; Harer, W.B.; Shif, C.J.; Baggett, D.; Carrigan, M. and Maret, S.M. (1994): Diagnosis of Plasmodium falciparum infections in mummies using the rapid manual ParaSightTM-F test, Trans R Soc Trop Med Hyg 88, pp.31-32.

Miller, S. A.; Dykes, D. D. and Polesky, H. F. (1988): A simple salting out procedure for extracting DNA from human nucleated cells, Nucleic Acids Res 16 [3], p.1215.

Mira, J. P.; Cariou, A.; Grall, F.; Delclaux, C.; Losser, M. R.; Heshmati, F.; Cheval, C.; Monchi, M.; Teboul, J. L.; Riche, F.; Leleu, G.; Arbibe, L.; Mignon, A.; Delpech, M. and Dhainaut, J. F. (1999): Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study, Jama 282 [6], pp.561-8.. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.ncbi.nlm.nih.gov/htbin-post/Omim/getmim%3ffield=medline_uid&search=10450718

Mire-Sluis, A.R. and Thorpe, R. (1998): Cytokines, 1.. ed., Academic Press, San Diego, California.

Mockenhaupt, F.; May, J.; Stark, K.; Falusi, A.G.; Meyer, C.G. and Bienzle, U. (1999): Serum transferrin receptor levels in Plasmodium falciparum-infection, Hematologica 84, pp.869-873.

Mockenhaupt, F. P.; Bienzle, U.; May, J.; Falusi, A. G.; Ademowo, O. G.; Olumese, P. E. and Meyer, C. G. (1999): Plasmodium falciparum infection: influence on hemoglobin levels in alpha-thalassemia and microcytosis, J Infect Dis 180 [3], pp.925-8. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.journals.uchicago.edu/cgi-bin/resolve%3fJID990065ABS

Mockenhaupt, F. P.; Falusi, A. G.; May, J.; Ademowo, O. G.; Olumese, P. E.; Meyer, C. G. and Bienzle, U. (1999): The contribution of alpha+-thalassaemia to anaemia in a Nigerian population exposed to intense malaria transmission, Trop Med Int Health 4 [4], pp.302-7.

Mockenhaupt, F.P.; May, J.; Bergqvist, Y.; Ademowo, O.G.; Olumese, P.E.; Falusi, A.G.; Großterlinden, L.; Meyer, C.G. and Bienzle, U. (2000): Concentrations of chloroquine and malaria parasites in Blood in Nigerian children, Antimcrobial Agents Chemother 44 [4], pp.835-839.

Mockenhaupt, F.P.; May, J.; Bergqyist, Y.; Meyer, C.G.; Falusi, A.G. and Bienzle, U. (im Druck): Evidence for a reduced effect of chloroquine against Plasmodium falciparum in a+-thalassaemic children, Trop Med Int Health.

Mockenhaupt, F. P.; May, J.; Bienzle, U. and Meyer, C. G. (1997): Medikamenten-resistente Malaria, Dtsch Med Wochenschr 122 [42], pp.1293-7.

Mockenhaupt, F. P.; May, J.; Eggelte, T. A.; Thies, F. L.; Ademowo, O. G.; Bienzle, U. and Meyer, C. G. (1999): Short report: high prevalence and imbalanced age distribution of the Plasmodium falciparum dihydrofolate reductase gene Asn108 mutation in an area of low pyrimethamine usage in Nigeria, Am J Trop Med Hyg 61 [3], pp.375-7.

Modiano, D.; Petrarca, V.; Sirima, B. S.; Nebie, I.; Diallo, D.; Esposito, F. and Coluzzi, M. (1996): Different response to Plasmodium falciparum malaria in west African sympatric ethnic groups, Proc Natl Acad Sci U S A 93 [23], pp.13206-11. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.pnas.org/cgi/content/full/93/23/13206

Mohamed, N. H.; Hamadto, H. H.; el-Fakahany, A. F.; Farrag, A. M. and el-Hamshary, A. M. (1992): Study of human and parasitic factors in relation to bancroftian filariasis in Egypt, J Egypt Soc Parasitol 22 [3], pp.719-27.

Mohamed, N. H.; Rifaat, M. A.; Abdel Baki, M. H.; el Okbi, L. M. and Farrag, A. M. (1987): Study of the relation between tissue typing and occurrence of filariasis and its complications in Egypt, J Egypt Soc Parasitol 17 [2], pp.751-8.

Mohan, K. and Stevenson, M. M. (1998): Acquired immunity to asexual blood stages, Sherman, I. W., Ed, Malaria - parasite biology, pathogenesis, and protection, 1. ed., pp. 467-493, ASM Press, Washington.

Molineaux, L.; Storey, J.; Cohen, J.E. and Thomas, A. (1980): A longitudinal study of human malaria in the West African Savanna in the absence of control measures: relationships between different Plasmodium species, in particular P. falciparum and P. malariae, Am J Trop Med Hyg 29 [725-737].

Molyneux, D. H.; Floyd, K.; Barnish, G. and Fevre, E. M. (1999): Transmission control and drug resistance in malaria: a crucial interaction, Parasitol Today 15 [6], pp.238-40.. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.biomednet.com/library/abstract/PT.part0699_01694758_v0015i06_00001453

Momburg, F.; Roelse, J.; Howard, J. C.; Butcher, G. W.; Hammerling, G. J. and Neefjes, J. J. (1994): Selectivity of MHC-encoded peptide transporters from human, mouse and rat, Nature 367 [6464], pp.648-51.

Mordmüller, B. G.; Metzger, W. G.; Juillard, P.; Brinkman, B. M.; Verweij, C. L.; Grau, G. E. and Kremsner, P. G. (1997): Tumor necrosis factor in Plasmodium falciparum malaria: high plasma level is associated with fever, but high production capacity is associated with rapid fever clearance, Eur Cytokine Netw 8 [1], pp.29-35.

Moreno, A.; Clavijo, P.; Edelman, R.; Davis, J.; Sztein, M.; Herrington, D. and Nardin, E. (1991): Cytotoxic CD4+ T cells from a sporozoite-immunized volunteer recognize the Plasmodium falciparum CS protein, Int Immunol 3 [10], pp.997-1003.

Morris, P.; Shaman, J.; Attaya, M.; Amaya, M.; Goodman, S.; Bergman, C.; Monaco, J. J. and Mellins, E. (1994): An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules, Nature 368 [6471], pp.551-4. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.ncbi.nlm.nih.gov/htbin-post/Omim/getmim%3ffield=medline_uid&search=8139689

Mshana, R. N.; Boulandi, J.; Mshana, N. M.; Mayombo, J. and Mendome, G. (1991): Cytokines in the pathogenesis of malaria: levels of IL-I beta, IL-4, IL- 6, TNF-alpha and IFN-gamma in plasma of healthy individuals and malaria patients in a holoendemic area, J Clin Lab Immunol 34 [3], pp.131-9.

Mshana, R. N.; McLean, S. and Boulandi, J. (1990): In vitro cell-mediated immune responses to Plasmodium falciparum schizont antigens in adults from a malaria endemic area: CD8+ T lymphocytes inhibit the response of low responder individuals, Int Immunol 2 [12], pp.1121-32.

Mulligan, H. W.; Russel, P. F. and Mohan, B. F. (1941): Active immunisation of fowls against Plasmodium gallinaceum by injection of killed homologous sporozoites, J. Malar. Inst. India 4, pp.25-34.

Mullis, K. B. and Faloona, F. A. (1987): Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction, Methods Enzymol 155, pp.335-50.

Murdoch, M. E.; Payton, A.; Abiose, A.; Thomson, W.; Panicker, V. K.; Dyer, P. A.; Jones, B. R.; Maizels, R. M. and Ollier, W. E. (1997): HLA-DQ alleles associate with cutaneous features of onchocerciasis. The Kaduna-London-Manchester Collaboration for Research on Onchocerciasis, Hum Immunol 55 [1], pp.46-52.

Murdoch, M. E.; Payton, A.; Abiose, A.; Thomson, W.; Panicker, V. K.; Dyer, P. A.; Jones, B. R.; Maizels, R. M. and Ollier, W. E. (1997): HLA-DQ alleles associate with cutaneous features of onchocerciasis. The Kaduna-London-Manchester Collaboration for Research on Onchocerciasis, Hum Immunol 55 [1], pp.46-52.

Murray, J. S. (1998): How the MHC selects Th1/Th2 immunity, Immunol Today 19 [4], pp.157-63. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.biomednet.com/library/fulltext/pii.S0167569997012371

Nadel, S.; Newport, M. J.; Booy, R. and Levin, M. (1996): Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease, J Infect Dis 174 [4], pp.878-80.. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.ncbi.nlm.nih.gov/htbin-post/Omim/getmim%3ffield=medline_uid&search=8843235

Nagel, R. L. (1990): Innate resistance to malaria: the intraerythrocytic cycle, Blood Cells 16 [2-3], pp.321-39.

Naik, P. and Voller, A (1984), Trans R Soc Trop Med Hyg 78 [812-813].

Nance, W.E. (1964): Genetic tests with a sex-linked marker: G6PD, Symposia of Quantitative Biology 415, Cold Spring Harb..

Nardin, E.H.; Herrington, D.A.; Davis, J.; Levine, M.; Stuber, D.; Takacs, B.; Caspers, P.; Barr, P.; Altszuler, R.; Clavijo, P. and Nussenzweig, R. S. (1989): Conserved repetitive epitope recognized by CD4+ clones from a malaria-immunized volunteer, Science 246, pp.1603-1606.

Nardin, E. H. and Zavala, F. (1998): Acquired immunity to sporozoites, Sherman, I. W., Ed, Malaria - parasite biology, pathogenesis, and protection, 1. ed., pp. 457-466, ASM Press, Washington.

Nash, G. B.; Cooke, B. M.; Marsh, K.; Berendt, A.; Newbold, C. and Stuart, J. (1992): Rheological analysis of the adhesive interactions of red blood cells parasitized by Plasmodium falciparum, Blood 79 [3], pp.798-807.

Nathan, C. (1997): Inducible nitric oxide synthase: what difference does it make?, J Clin Invest 100 [10], pp.2417-23. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.jci.org/cgi/content/full/100/10/2417

Ndiaye, M.; Thiam, A.; Ndiaye, R.; Angel, G.; Seignot, P.; Roussilhon, C.; Sarthou, J. L. and Dieye, A. (1998): [Susceptibility to neuro-malaria and HLA-DR alleles in Senegal], Dakar Med 43 [1], pp.25-8.

Neequaye, J. (1986): In vivo chloroquine-resistant falciparum malaria in western Africa, Lancet 1 [8473], pp.153-4..

Nepom, G. T.; Byers, P.; Seyfried, C.; Healey, L. A.; Wilske, K. R.; Stage, D. and Nepom, B. S. (1989): HLA genes associated with rheumatoid arthritis. Identification of susceptibility alleles using specific oligonucleotide probes, Arthritis Rheum 32 [1], pp.15-21.

Nevinny-Stickel, C.; Bettinotti, M. D.; Andreas, A.; Hinzpeter, M.; Muhlegger, K.; Schmitz, G. and Albert, E. D. (1991): Nonradioactive HLA class II typing using polymerase chain reaction and digoxigenin-11-2'-3'-dideoxy-uridinetriphosphate-labeled oligonucleotide probes, Hum Immunol 31 [1], pp.7-13.

Newbold, C.; Warn, P.; Black, G.; Berendt, A.; Craig, A.; Snow, B.; Msobo, M.; Peshu, N. and Marsh, K. (1997): Receptor-specific adhesion and clinical disease in Plasmodium falciparum, Am J Trop Med Hyg 57 [4], pp.389-98.

Nomura, T.; Carlton, J. M.; Baird, J. K.; del Portillo, H. A.; Fryauff, D. J.; Rathore, D.; Fidock, D. A.; Su, Xz; Collins, W. E.; McCutchan, T. F.; Wootton, J. C. and Wellems, T. E. (2001): Evidence for different mechanisms of chloroquine resistance in 2 plasmodium species that cause human malaria, J Infect Dis 183 [11], pp.1653-61..

Ntoumi, F.; Mercereau-Puijalon, O.; Ossari, S.; Luty, A.; Reltien, J.; Georges, A. and Millet, P. (1997): Plasmodium falciparum: sickle-cell trait is associated with higher prevalence of multiple infections in Gabonese children with asymptomatic infections, Exp Parasitol 87 [1], pp.39-46. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.idealibrary.com/links/citation/0014-4894/87/39

Nudelman, S.; Renia, L.; Charoenvit, Y.; Yuan, L.; Miltgen, F.; Beaudoin, R. L. and Mazier, D. (1989): Dual action of anti-sporozoite antibodies in vitro, J Immunol 143 [3], pp.996-1000.

Nuntayanuwat, S.; Dharakul, T.; Chaowagul, W. and Songsivilai, S. (1999): Polymorphism in the promoter region of tumor necrosis factor-alpha gene is associated with severe meliodosis, Hum Immunol 60 [10], pp.979-83..

Nussler, A.; Drapier, J. C.; Renia, L.; Pied, S.; Miltgen, F.; Gentilini, M. and Mazier, D. (1991): L-arginine-dependent destruction of intrahepatic malaria parasites in response to tumor necrosis factor and/or interleukin 6 stimulation, Eur J Immunol 21 [1], pp.227-30.

Nuwaha, F. (2001): The challenge of chloroquine-resistant malaria in sub-Saharan Africa, Health Policy Plan 16 [1], pp.1-12.. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://heapol.oupjournals.org/cgi/content/abstract/16/1/1

Okoyeh, J. N.; Pillai, C. R. and Chitnis, C. E. (1999): Plasmodium falciparum field isolates commonly use erythrocyte invasion pathways that are independent of sialic acid residues of glycophorin A, Infect Immun 67 [11], pp.5784-91. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://iai.asm.org/cgi/content/full/67/11/5784

Orago, A. S. and Facer, C. A. (1991): Cytotoxicity of human natural killer (NK) cell subsets for Plasmodium falciparum erythrocytic schizonts: stimulation by cytokines and inhibition by neomycin, Clin Exp Immunol 86 [1], pp.22-9.

Orr, H. T.; Lopez de Castro, J. A.; Parham, P.; Ploegh, H. L. and Strominger, J. L. (1979): Comparison of amino acid sequences of two human histocompatibility antigens, HLA-A2 and HLA-B7: location of putative alloantigenic sites, Proc Natl Acad Sci U S A 76 [9], pp.4395-9.

Ortmann, B.; Copeman, J.; Lehner, P. J.; Sadasivan, B.; Herberg, J. A.; Grandea, A. G.; Riddell, S. R.; Tampe, R.; Spies, T.; Trowsdale, J. and Cresswell, P. (1997): A critical role for tapasin in the assembly and function of multimeric MHC class I-TAP complexes, Science 277 [5330], pp.1306-9. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.ncbi.nlm.nih.gov/htbin-post/Omim/getmim%3ffield=medline_uid&search=9271576

Oski, F.A. (1992): Differential diagnosis of anemia, Nathan, D.G. and Oski, F.A., Eds, Hematology of infancy and childhood, pp. 346-353, W B Saunders, Philadelphia.

Ossendorp, F.; Mengede, E.; Camps, M.; Filius, R. and Melief, C. J. (1998): Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors, J Exp Med 187 [5], pp.693-702. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.jem.org/cgi/content/full/187/5/693

Othoro, C.; Lal, A. A.; Nahlen, B.; Koech, D.; Orago, A. S. and Udhayakumar, V. (1999): A low interleukin-10 tumor necrosis factor-alpha ratio is associated with malaria anemia in children residing in a holoendemic malaria region in western Kenya, J Infect Dis 179 [1], pp.279-82. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.journals.uchicago.edu/cgi-bin/resolve%3fJID980325ABS

Pasquetto, V.; Fidock, D. A.; Gras, H.; Badell, E.; Eling, W.; Ballou, W. R.; Belghiti, J.; Tartar, A. and Druilhe, P. (1997): Plasmodium falciparum sporozoite invasion is inhibited by naturally acquired or experimentally induced polyclonal antibodies to the STARP antigen, Eur J Immunol 27 [10], pp.2502-13.

Pasvol, G. and Weatherall, D. J. (1980): The red cell and the malarial parasite, Br J Haematol 46 [2], pp.165-70.

Pasvol, G.; Weatherall, D. J. and Wilson, R. J. (1977): Effects of foetal haemoglobin on susceptibility of red cells to Plasmodium falciparum, Nature 270 [5633], pp.171-3.

Pasvol, G.; Weatherall, D. J. and Wilson, R. J. (1978): Cellular mechanism for the protective effect of haemoglobin S against P. falciparum malaria, Nature 274 [5672], pp.701-3.

Pattanapanyasat, K.; Yongvanitchit, K.; Tongtawe, P.; Tachavanich, K.; Wanachiwanawin, W.; Fucharoen, S. and Walsh, D. S. (1999): Impairment of Plasmodium falciparum growth in thalassemic red blood cells: further evidence by using biotin labeling and flow cytometry, Blood 93 [9], pp.3116-9. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.bloodjournal.org/cgi/content/full/93/9/3116 http://www.bloodjournal.org/cgi/content/full/93/9/3116

Payne, D.; Grab, B.; Fontaine, R. E. and Hempel, J. H. (1976): Impact of control measures on malaria transmission and general mortality, Bull World Health Organ 54 [4], pp.369-77.

Peh, C. A.; Burrows, S. R.; Barnden, M.; Khanna, R.; Cresswell, P.; Moss, D. J. and McCluskey, J. (1998): HLA-B27-restricted antigen presentation in the absence of tapasin reveals polymorphism in mechanisms of HLA class I peptide loading, Immunity 8 [5], pp.531-42. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.immunity.com/cgi/content/full/8/5/531

Peterson, D. S.; Milhous, W. K. and Wellems, T. E. (1990): Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria, Proc Natl Acad Sci U S A 87 [8], pp.3018-22..

Peterson, D. S.; Walliker, D. and Wellems, T. E. (1988): Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria, Proc Natl Acad Sci U S A 85 [23], pp.9114-8..

Petrovsky, N. and Harrison, L.C. (1997): HLA class II-associated polymorphism of interferon-g production, Human Immunology 53, pp.12-16.

Petzl-Erler, M. L.; Belich, M. P. and Queiroz-Telles, F. (1991): Association of mucosal leishmaniasis with HLA, Hum Immunol 32 [4], pp.254-60.

Phillips, R. E.; Looareesuwan, S.; Warrell, D. A.; Lee, S. H.; Karbwang, J.; Warrell, M. J.; White, N. J.; Swasdichai, C. and Weatherall, D. J. (1986): The importance of anaemia in cerebral and uncomplicated falciparum malaria: role of complications, dyserythropoiesis and iron sequestration, Q J Med 58 [227], pp.305-23.

Phillips, R. E. and Pasvol, G. (1992): Anaemia of Plasmodium falciparum malaria, Baillieres Clin Haematol 5 [2], pp.315-30.

Pillai, D. R.; Labbe, A. C.; Vanisaveth, V.; Hongvangthong, B.; Pomphida, S.; Inkathone, S.; Zhong, K. and Kain, K. C. (2001): Plasmodium falciparum malaria in Laos: chloroquine treatment outcome and predictive value of molecular markers, J Infect Dis 183 [5], pp.789-95..

Playfair, J. H. (1982): Immunity to malaria, Br Med Bull 38 [2], pp.153-9.

Plebanski, M.; Aidoo, M.; Whittle, H. C. and Hill, A. V. (1997b): Precursor frequency analysis of cytotoxic T lymphocytes to pre- erythrocytic antigens of Plasmodium falciparum in West Africa, J Immunol 158 [6], pp.2849-55. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.jimmunol.org/cgi-bin/Retreiver.cgi/v158n6/2849/2849-abs-frame.html

Plebanski, M.; Flanagan, K.L.; Lee, E.A.M.; Reece, W.H.H.; Hart, K.; Gelder, C.; Gillespie, G.; Pinder, M. and Hill, A.V.S. (1999): Interleukin 10-mediated immunosuppression by a variant CD4 T cell epitope of Plasmodium falciparum, Immunity 10, pp.651-660.

Plebanski, M. and Hill, A. V. (2000): The immunology of malaria infection, Curr Opin Immunol 12 [4], pp.437-41. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.biomednet.com/article/imc406

Plebanski, M.; Lee, E. A. and Hill, A. V. (1997a): Immune evasion in malaria: altered peptide ligands of the circumsporozoite protein, Parasitology 115 [Suppl], pp.S55-66.

Plowe, C. V.; Cortese, J. F.; Djimde, A.; Nwanyanwu, O. C.; Watkins, W. M.; Winstanley, P. A.; Estrada-Franco, J. G.; Mollinedo, R. E.; Avila, J. C.; Cespedes, J. L.; Carter, D. and Doumbo, O. K. (1997): Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine- sulfadoxine use and resistance, J Infect Dis 176 [6], pp.1590-6..

Plowe, C. V.; Djimde, A.; Bouare, M.; Doumbo, O. and Wellems, T. E. (1995): Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa, Am J Trop Med Hyg 52 [6], pp.565-8..

Pociot, F.; D'Alfonso, S.; Compasso, S.; Scorza, R. and Richiardi, P. M. (1995): Functional analysis of a new polymorphism in the human TNF alpha gene promoter, Scand J Immunol 42 [4], pp.501-4.

Porter, I.H.; Boyer, S.H.; Watson-Williams, E.J.; Adam, A.; Szeinberg, A. and Siniscalco, M (1964): Variation of Glucose-6-Phosphate Dehydrogenase in different populations, Lancet i, p.895.

Powis, S. H.; Tonks, S.; Mockridge, I.; Kelly, A. P.; Bodmer, J. G. and Trowsdale, J. (1993): Alleles and haplotypes of the MHC-encoded ABC transporters TAP1 and TAP2, Immunogenetics 37 [5], pp.373-80.

Pringle, G. and Avery-Jones, S. (1966): Observations on the early course of untreated falciparum malaria in semi-immune African children following a short period of protection, Bull World Health Organ 34 [2], pp.269-72.

Quadri, S. A. and Singal, D. P. (1998): Peptide transport in human lymphoblastoid and tumor cells: effect of transporter associated with antigen presentation (TAP) polymorphism, Immunol Lett 61 [1], pp.25-31.

Rau, H.; Nicolay, A.; Usadel, K. H.; Finke, R.; Donner, H.; Walfish, P. G. and Badenhoop, K. (1997): Polymorphisms of TAP1 and TAP2 genes in Graves' disease, Tissue Antigens 49 [1], pp.16-22.

Redd, S.C.; Wirima, J.J. and Steketee, R.W. (1994): Risk factors for anemia in young children in rural Malawi, Am J Trop Med Hyg 51, pp.170-174.

Rénia, L.; Grillot, D.; Marussig, M.; Corradin, G.; Miltgen, F.; Lambert, P.H.; Mazier, D. and Del Giudice, G. (1993): Effector functions of circumsporocoite peptide-primed CD4+ T cell clones against Plasmodium yoelii liver stages, J Immunol 150, pp.1471-1478.

Renia, L.; Marussig, M. S.; Grillot, D.; Pied, S.; Corradin, G.; Miltgen, F.; Del Giudice, G. and Mazier, D. (1991): In vitro activity of CD4+ and CD8+ T lymphocytes from mice immunized with a synthetic malaria peptide, Proc Natl Acad Sci U S A 88 [18], pp.7963-7..

Rénia, L.; Mattei, D.; Goma, J.; Pied, S.; Dubois, P.; Miltgen, F.; Nussler, A.; Matile, H.; Menegaux, F.; Gentilini, M. and et al. (1990): A malaria heat-shock-like determinant expressed on the infected hepatocyte surface is the target of antibody-dependent cell-mediated cytotoxic mechanisms by nonparenchymal liver cells, Eur J Immunol 20 [7], pp.1445-9.

Rénia, L.; Rodrigues, M. M. and Nussenzweig, V. (1994): Intrasplenic immunization with infected hepatocytes: a mouse model for studying protective immunity against malaria pre-erythrocytic stage, Immunology 82 [1], pp.164-8.

Reynard, M. P.; Turner, D. and Navarrete, C. V. (2000): Allele frequencies of polymorphisms of the tumour necrosis factor- alpha, interleukin-10, interferon-gamma and interleukin-2 genes in a north european caucasoid group from the UK, Eur J Immunogenet 27 [4], pp.241-9..

Richie, T.L. (1988): Interactions between malaria parasites infecting the same vertebrate host, Parasitology 96, pp.607-639.

Rihet, P.; Traore, Y.; Abel, L.; Aucan, C.; Traore-Leroux, T. and Fumoux, F. (1998): Malaria in humans: Plasmodium falciparum blood infection levels are linked to chromosome 5q31-q33, Am J Hum Genet 63 [2], pp.498-505. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.ncbi.nlm.nih.gov/htbin-post/Omim/getmim%3ffield=medline_uid&search=9683598 http://www.journals.uchicago.edu/cgi-bin/resolve?AJHG980143ABS

Riley, E. M.; Jakobsen, P. H.; Allen, S. J.; Wheeler, J. G.; Bennett, S.; Jepsen, S. and Greenwood, B. M. (1991): Immune response to soluble exoantigens of Plasmodium falciparum may contribute to both pathogenesis and protection in clinical malaria: evidence from a longitudinal, prospective study of semi-immune African children, Eur J Immunol 21 [4], pp.1019-25.

Riley, E. M.; Olerup, O.; Bennett, S.; Rowe, P.; Allen, S. J.; Blackman, M. J.; Troye-Blomberg, M.; Holder, A. A. and Greenwood, B. M. (1992): MHC and malaria: the relationship between HLA class II alleles and immune responses to Plasmodium falciparum, Int Immunol 4 [9], pp.1055-63.

Ringwald, P.; Peyron, F.; Vuillez, J. P.; Touze, J. E.; Le Bras, J. and Deloron, P. (1991): Levels of cytokines in plasma during Plasmodium falciparum malaria attacks, J Clin Microbiol 29 [9], pp.2076-8.

Robert, F.; Ntoumi, F.; Angel, G.; Candito, D.; Rogier, C.; Fandeur, T.; Sarthou, J. L. and Mercereau-Puijalon, O. (1996): Extensive genetic diversity of Plasmodium falciparum isolates collected from patients with severe malaria in Dakar, Senegal, Trans R Soc Trop Med Hyg 90 [6], pp.704-11.

Robinson, J.; Malik, A.; Parham, P.; Bodmer, J. G. and Marsh, S. G. (2000): IMGT/HLA database--a sequence database for the human major histocompatibility complex, Tissue Antigens 55 [3], pp.280-7.

Rockett, K. A.; Awburn, M. M.; Aggarwal, B. B.; Cowden, W. B. and Clark, I. A. (1992): In vivo induction of nitrite and nitrate by tumor necrosis factor, lymphotoxin, and interleukin-1: possible roles in malaria, Infect Immun 60 [9], pp.3725-30.

Rockett, K. A.; Awburn, M. M.; Cowden, W. B. and Clark, I. A. (1991): Killing of Plasmodium falciparum in vitro by nitric oxide derivatives, Infect Immun 59 [9], pp.3280-3.

Romia, S. A.; el-Ganayni, G. A.; Makhlouf, L. M. and Handousa, A. E. (1988): HLA antigens and blood groups in bancroftian filariasis, J Egypt Soc Parasitol 18 [1], pp.211-20.

Rønningen, K. S.; Undlien, D. E.; Ploski, R.; Maouni, N.; Konrad, R. J.; Jensen, E.; Hornes, E.; Reijonen, H.; Colonna, M.; Monos, D. S. and et al. (1993): Linkage disequilibrium between TAP2 variants and HLA class II alleles; no primary association between TAP2 variants and insulin-dependent diabetes mellitus, Eur J Immunol 23 [5], pp.1050-6.

Roodman, G. D.; Bird, A.; Hutzler, D. and Montgomery, W. (1987): Tumor necrosis factor-alpha and hematopoietic progenitors: effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, HL60, and HEL cells, Exp Hematol 15 [9], pp.928-35.

Roper, C.; Elhassan, I. M.; Hviid, L.; Giha, H.; Richardson, W.; Babiker, H.; Satti, G. M.; Theander, T. G. and Arnot, D. E. (1996): Detection of very low level Plasmodium falciparum infections using the nested polymerase chain reaction and a reassessment of the epidemiology of unstable malaria in Sudan, Am-J-Trop-Med-Hyg 54 [4], pp.325-31.

Rosario, V. E.; Hall, R.; Walliker, D. and Beale, G. H. (1978): Persistence of drug-resistant malaria parasites, Lancet 1 [8057], pp.185-7..

Ross, R. (1923): Memoires - with a full account of the great malaria problem and its solution, Murray, London, United Kington.

Roth, Ef Jr; Raventos, Suarez C.; Rinaldi, A. and Nagel, R. L. (1983): Glucose-6-phosphate dehydrogenase deficiency inhibits in vitro growth of Plasmodium falciparum, Proc Natl Acad Sci U S A 80 [1], pp.298-9.

Rowland, P. G.; Nash, G. B.; Cooke, B. M. and Stuart, J. (1993): Comparative study of the adhesion of sickle cells and malarial- parasitized red cells to cultured endothelium, J Lab Clin Med 121 [5], pp.706-13.

Roy, S.; McGuire, W.; Mascie-Taylor, C. G.; Saha, B.; Hazra, S. K.; Hill, A. V. and Kwiatkowski, D. (1997): Tumor necrosis factor promoter polymorphism and susceptibility to lepromatous leprosy, J Infect Dis 176 [2], pp.530-2.. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.ncbi.nlm.nih.gov/htbin-post/Omim/getmim%3ffield=medline_uid&search=9237725

Rubio, J. P.; Triglia, T.; Kemp, D. J.; de Bruin, D.; Ravetch, J. V. and Cowman, A. F. (1995): A YAC contig map of Plasmodium falciparum chromosome 4: characterization of a DNA amplification between two recently separated isolates, Genomics 26 [2], pp.192-8.

Ruwende, C.; Khoo, S. C.; Snow, R. W.; Yates, S. N.; Kwiatkowski, D.; Gupta, S.; Warn, P.; Allsopp, C. E.; Gilbert, S. C.; Peschu, N. and et, a. l. (1995): Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria, Nature 376 [6537], pp.246-9.

Sabchareon, A.; Burnouf, T.; Ouattara, D.; Attanath, P.; Bouharoun-Tayoun, H.; Chantavanich, P.; Foucault, C.; Chongsuphajaisiddhi, T. and Druilhe, P. (1991): Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria, Am J Trop Med Hyg 45 [3], pp.297-308.

Sachs, J.A.; Whichelow, C.E.; Hitman, G.A.; Niven, M.; Thode, H. and Meager, A. (1990): The effect of HLA and insulin-dependent diabetes mellitus on the secretion levels of tumour necrosis factor alpha and beta and gamma interferon, Scand J Immunol 32, p.703.

Saiki, R. K.; Bugawan, T. L.; Horn, G. T.; Mullis, K. B. and Erlich, H. A. (1986): Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes, Nature 324 [6093], pp.163-6. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://locus.umdnj.edu/ccr/ccr_cgi/pubmed.cgi%3f3785382

Saiki, R. K.; Scharf, S.; Faloona, F.; Mullis, K. B.; Horn, G. T.; Erlich, H. A. and Arnheim, N. (1985): Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia, Science 230 [4732], pp.1350-4. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://locus.umdnj.edu/ccr/ccr_cgi/pubmed.cgi%3f2999980

Saiki, R. K.; Walsh, P. S.; Levenson, C. H. and Erlich, H. A. (1989): Genetic analysis of amplified DNA with immobilized sequence-specific oligonucleotide probes, Proc Natl Acad Sci U S A 86 [16], pp.6230-4.

Salako, L.A.; Ajayi, F.O.; Sowumni, A. and Walker, O. (1990): Malaria in Nigeria: a revisit, Annals of Tropical Medicine and Parasitology 84, pp.435-445.

Sambrook, J.; Fritsch, E. and Maniatis, T. (1989): Molecular cloning. A laboratory manual, 2. ed., Cold Spring Harbour Laboratory Press, New York.

Sanders, K.J. and Lewis, S.M. (1988): Screening for glucose-6-phosphate dehydrogenase deficiency, pp. 76-78.

Sanger, F.; Air, G. M.; Barrell, B. G.; Brown, N. L.; Coulson, A. R.; Fiddes, C. A.; Hutchison, C. A.; Slocombe, P. M. and Smith, M. (1977): Nucleotide sequence of bacteriophage phi X174 DNA, Nature 265 [5596], pp.687-95.

Sanger, F.; Nicklen, S. and Coulson, A. R. (1977): DNA sequencing with chain-terminating inhibitors, Proc Natl Acad Sci U S A 74 [12], pp.5463-7.

Sant, A. J. and Germain, R. N. (1989): Intracellular competition for component chains determines class II MHC cell surface phenotype, Cell 57 [5], pp.797-805.

Satoh, M.; Toma, H.; Sato, Y.; Kikuchi, M.; Takara, M.; Shiroma, Y.; Kiyuna, S. and Hirayama, K. (1999): Production of a high level of specific IgG4 antibody associated with resistance to albendazole treatment in HLA-DRB1*0901-positive patients with strongyloidiasis, Am J Trop Med Hyg 61 [4], pp.668-71.

Saul, A. (1999): The role of variant surface antigens on malaria-infected red blood cells, Parasitology Today 15, pp.455-457.

Schellenberg, D.; Menendez, C.; Kahigwa, E.; Aponte, J.; Vidal, J.; Tanner, M.; Mshinda, H. and Alonso, P. (2001): Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo- controlled trial, Lancet 357 [9267], pp.1471-7..

Scherf, A.; Mattei, D. and Sarthou, J. L. (1991): Multiple infections and unusual distribution of block 2 of the MSA1 gene of Plasmodium falciparum detected in west African clinical isolates by polymerase chain reaction analysis, Mol Biochem Parasitol 44 [2], pp.297-9.

Schmidt-Ott, R.; Luckner, D.; Lehman, L. G.; Lell, B.; Matousek, P.; Greve, B. and Kremsner, P. G. (1997): Pyrimethamine/sulfadoxine for treating uncomplicated Plasmodium falciparum malaria in young children in Gabon, Trans R Soc Trop Med Hyg 91 [5], pp.578-9.

Schmitz, G. G.; Walter, T.; Seibl, R. and Kessler, C. (1991): Nonradioactive labeling of oligonucleotides in vitro with the hapten digoxigenin by tailing with terminal transferase, Anal Biochem 192 [1], pp.222-31.

Schnittger, L.; May, J.; Kretschmer, C.; Kremsner, P. G. and Meyer, C. G. (1996): DPB1*BR: an Mhc class II DPB1 allele (DPB1*6601) of negroid origin, Immunogenetics 44 [5], pp.405-6.

Schnittger, L.; May, J.; Loeliger, C. C.; Gallin, M. Y.; Erttmann, K. D.; Bienzle, U.; Kremsner, P. G. and Meyer, C. G. (1997): HLA DRB1-DQA1-DQB1 haplotype diversity in two African populations, Tissue Antigens 50 [5], pp.546-51.

Schofield, L.; Novakovic, S.; Gerold, P.; Schwarz, R. T.; McConville, M. J. and Tachado, S. D. (1996): Glycosylphosphatidylinositol toxin of Plasmodium up-regulates intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin expression in vascular endothelial cells and increases leukocyte and parasite cytoadherence via tyrosine kinase-dependent signal transduction, J Immunol 156 [5], pp.1886-96. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.jimmunol.org/cgi-bin/Retreiver.cgi/v156n5/1886/1886-abs-frame.html

Scholander, C.; Carlson, J.; Kremsner, P. G. and Wahlgren, M. (1998): Extensive immunoglobulin binding of Plasmodium falciparum-infected erythrocytes in a group of children with moderate anemia, Infect Immun 66 [1], pp.361-3. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://iai.asm.org/cgi/content/full/66/1/361

Schwenke, A.; Brandts, C.; Philipps, J.; Winkler, S.; Wernsdorfer, W. H. and Kremsner, P. G. (2001): Declining chloroquine resistance of Plasmodium falciparum in Lambarene, Gabon from 1992 to 1998, Wien Klin Wochenschr 113 [1-2], pp.63-4..

Secor, W. E.; del Corral, H.; dos Reis, M. G.; Ramos, E. A.; Zimon, A. E.; Matos, E. P.; Reis, E. A.; do Carmo, T. M.; Hirayama, K.; David, R. A.; David, J. R. and Harn, D. A., Jr. (1996): Association of hepatosplenic schistosomiasis with HLA-DQB1*0201, J Infect Dis 174 [5], pp.1131-5.

Servenius, B.; Gustafsson, K.; Widmark, E.; Emmoth, E.; Andersson, G.; Larhammar, D.; Rask, L. and Peterson, P. A. (1984): Molecular map of the human HLA-SB (HLA-DP) region and sequence of an SB alpha (DP alpha) pseudogene, Embo J 3 [13], pp.3209-14.

Shaffer, N.; Grau, G. E.; Hedberg, K.; Davachi, F.; Lyamba, B.; Hightower, A. W.; Breman, J. G. and Phuc, N. D. (1991): Tumor necrosis factor and severe malaria, J Infect Dis 163 [1], pp.96-101.

Shaw, S.; Johnson, A. H. and Shearer, G. M. (1980): Evidence for a new segregant series of B cell antigens that are encoded in the HLA-D region and that stimulate secondary allogenic proliferative and cytotoxic responses, J Exp Med 152 [3], pp.565-80. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.ncbi.nlm.nih.gov/htbin-post/Omim/getmim%3ffield=medline_uid&search=6967946

Sheagren, J. N.; Tobie, J. E.; Fox, L. M. and Wolff, S. M. (1970): Reticuloendothelial system phagocytic function in naturally acquired human malaria, J Lab Clin Med 75 [3], pp.481-7.

Sherman, I.W. (1998): A brief history of malaria and discovery of the parasite's life cycle, Sherman, I.W., Ed, Malaria - parasite biology, pathogenesis, and protection, 1. ed., pp. 3-10, ASM Press, Washington.

Sherman, I.W. and Winograd, E. (1990): Antigens on the Plasmodium falciparum infected erythrocyte surface are not parasite derived, Parasitology Today 6, pp.317-320.

Shi, L.; Yan, G.; Fu, Y.; Ma, L.; Penfornis, A. and Faustman, D. (1997): Human TAP1 polymorphisms detected by denaturing gradient gel electrophoresis, Tissue Antigens 49 [4], pp.421-6.

Sidney, J.; Grey, H. M.; Kubo, R. T. and Sette, A. (1996): Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs, Immunol Today 17 [6], pp.261-6..

Sijts, A. J. and Pamer, E. G. (1997): Enhanced intracellular dissociation of major histocompatibility complex class I-associated peptides: a mechanism for optimizing the spectrum of cell surface-presented cytotoxic T lymphocyte epitopes, J Exp Med 185 [8], pp.1403-11. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.jem.org/cgi/content/full/185/8/1403

Singh, N.; Sundar, S.; Williams, F.; Curran, M. D.; Rastogi, A.; Agrawal, S. and Middleton, D. (1997): Molecular typing of HLA class I and class II antigens in Indian kala- azar patients, Trop Med Int Health 2 [5], pp.468-71.

Smetanina, N.S. and Huisman, T.H.J. (1996): Detection of a-thalassemia-2 and its corresponding triplication aaa (anti-3.7 kb) by PCR: an improved technical change, Am J Hematol 48, pp.202-3.

Smith, J. D.; Chitnis, C. E.; Craig, A. G.; Roberts, D. J.; Hudson-Taylor, D. E.; Peterson, D. S.; Pinches, R.; Newbold, C. I. and Miller, L. H. (1995): Switches in expression of Plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes, Cell 82 [1], pp.101-10.

Smith, T. A.; Leuenberger, R. and Lengeler, C. (2001): Child mortality and malaria transmission intensity in Africa, Trends Parasitol 17 [3], pp.145-9..

Smythe, J. A.; Peterson, M. G.; Coppel, R. L.; Saul, A. J.; Kemp, D. J. and Anders, R. F. (1990): Structural diversity in the 45-kilodalton merozoite surface antigen of Plasmodium falciparum, Mol Biochem Parasitol 39 [2], pp.227-34.

Snewin, V. A.; England, S. M.; Sims, P. F. and Hyde, J. E. (1989): Characterisation of the dihydrofolate reductase-thymidylate synthetase gene from human malaria parasites highly resistant to pyrimethamine, Gene 76 [1], pp.41-52..

Snounou, G.; Bourne, T.; Jarra, W.; Viriyakasol, S.; Wood, J.C. and Brown, K.N. (1993): Assessment of parasite population dynamics in mixed infections of rodent plasmodia, Parasitology 105, pp.363-374.

Snounou, G.; Pinheiro, L.; Goncalves, A.; Fonseca, L.; Dias, F.; Brown, K.N. and do Rosario, V. (1993): The importance of sensitive detection of malaria parasites in the human and insect hosts in epidemiological studies, as shown by the analysis of field samples from Guinea-Bissau, Transactions of the Royal Society of Tropical Medicine and Hygiene 87, pp.649-653.

Snounou, G.; Viriyakasol, S.; Zhu, X.P.; Jarra, W.; Pinheiro, L.; do Rosario, V.E.; Thaitong, S. and Brown, K.N. (1993): High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction, Molecular and Biochemical Parasitology 61, pp.315-320.

Snounou, G.; Viriyakosol, S.; Jarra, W.; Thaithong, S. and Brown, K. N. (1993): Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections, Molecular and Biochemical Parasitology 58, pp.283-292.

Snow, R.K. and Marsh, K. (1995): Will reducing Plasmodium falciparum transmission alter malaria mortality among African children?, Parasitology Today 11, pp.188-190.

Snow, R. W.; Craig, M.; Deichmann, U. and Marsh, K. (1999): Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population, Bull World Health Organ 77 [8], pp.624-40.

Snow, R. W.; Omumbo, J. A.; Lowe, B.; Molyneux, C. S.; Obiero, J. O.; Palmer, A.; Weber, M. W.; Pinder, M.; Nahlen, B.; Obonyo, C.; Newbold, C.; Gupta, S. and Marsh, K. (1997): Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa, Lancet 349 [9066], pp.1650-4..

Staalsoe, T. and Hviid, L. (1998): The role of variant-specific immunity in asymptomatic malaria infections: maintaining a fine balance, Parasitology Today 14 [5], pp.177-178.

Stark, K.; Meyer, C. G.; Tacke, M.; Schwarz, A.; Braun, C.; Huzly, D.; Engel, A. M.; May, J. and Bienzle, U. (1997): Hepatitis G virus RNA and hepatitis G virus antibodies in renal transplant recipients: prevalence and risk factors, Transplantation 64 [4], pp.608-12.

Stern, L. J.; Brown, J. H.; Jardetzky, T. S.; Gorga, J. C.; Urban, R. G.; Strominger, J. L. and Wiley, D. C. (1994): Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide, Nature 368 [6468], pp.215-21.

Stirnadel, H. A.; Beck, H. P.; Alpers, M. P. and Smith, T. A. (1999): Heritability and segregation analysis of immune responses to specific malaria antigens in Papua New Guinea, Genet Epidemiol 17 [1], pp.16-34.

Stirnadel, H. A.; Stockle, M.; Felger, I.; Smith, T.; Tanner, M. and Beck, H. P. (1999): Malaria infection and morbidity in infants in relation to genetic polymorphisms in Tanzania, Trop Med Int Health 4 [3], pp.187-93.

Stirnadel, H. A.; Stockle, M.; Felger, I.; Smith, T.; Tanner, M. and Beck, H. P. (1999): Malaria infection and morbidity in infants in relation to genetic polymorphisms in Tanzania, Trop Med Int Health 4 [3], pp.187-93.

Stoute, J.A.; Slaoui, A.; Heppner, M.; Momin, P.; Kester, K.E.; Desmons, P.; Wellde, B.T.; Garcon, N.; Krzych, U.; Marchand, M.; Ballou, W.R. and Cohen, J.D. (1997): A preleminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria, N Engl J Med 336 [86-91].

Stuber, F.; Petersen, M.; Bokelmann, F. and Schade, U. (1996): A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis, Crit Care Med 24 [3], pp.381-4.

Su, X.; Ferdig, M. T.; Huang, Y.; Huynh, C. Q.; Liu, A.; You, J.; Wootton, J. C. and Wellems, T. E. (1999): A genetic map and recombination parameters of the human malaria parasite Plasmodium falciparum, Science 286 [5443], pp.1351-3.. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.sciencemag.org/cgi/content/full/286/5443/1351

Su, X.; Kirkman, L. A.; Fujioka, H. and Wellems, T. E. (1997): Complex polymorphisms in an approximately 330 kDa protein are linked to chloroquine-resistant P. falciparum in Southeast Asia and Africa, Cell 91 [5], pp.593-603. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.cell.com/cgi/content/full/91/5/593

Su, X. Z.; Carucci, D. J. and Wellems, T. E. (1998): Plasmodium falciparum: parasite typing by using a multicopy microsatellite marker, PfRRM, Exp Parasitol 89 [2], pp.262-5. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.idealibrary.com/links/citation/0014-4894/89/262

Su, X. Z.; Heatwole, V. M.; Wertheimer, S. P.; Guinet, F.; Herrfeldt, J. A.; Peterson, D. S.; Ravetch, J. A. and Wellems, T. E. (1995): The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of Plasmodium falciparum-infected erythrocytes, Cell 82 [1], pp.89-100.

Su, X. Z. and Wellems, T. E. (1997): Plasmodium falciparum: a rapid DNA fingerprinting method using microsatellite sequences within var clusters, Exp Parasitol 86 [3], pp.235-6. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.idealibrary.com/links/citation/0014-4894/86/235

Su, X. Z. and Wellems, T. E. (1999): Plasmodium falciparum: assignment of microsatellite markers to chromosomes by PFG-PCR, Exp Parasitol 91 [4], pp.367-9. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.idealibrary.com/links/citation/0014-4894/91/367

Su, X.-Z. and Wellems, T. E. (1996): Toward a high-resolution Plasmodium falciparum linkage map: polymorphic markers from hundreds of simple sequence repeats, Genomics 33 [3], pp.430-44. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.idealibrary.com/links/citation/0888-7543/33/430

Sulzer, A.J. and Wilson, M. (1971): The fluorescent antibody test for malaria, CRC Crit Rev Clin Lab Sci 2, pp.601-619.

Sylla, E. H.; Kun, J. F. and Kremsner, P. G. (2000): Mosquito distribution and entomological inoculation rates in three malaria-endemic areas in Gabon, Trans R Soc Trop Med Hyg 94 [6], pp.652-6..

Tanabe, K.; Mackay, M.; Goman, M. and Scaife, J. G. (1987): Allelic dimorphism in a surface antigen gene of the malaria parasite Plasmodium falciparum, J Mol Biol 195 [2], pp.273-87.

Tanaka, K.; Tanahashi, N.; Tsurumi, C.; Yokota, K. Y. and Shimbara, N. (1997): Proteasomes and antigen processing, Adv Immunol 64, pp.1-38.

Tang, J.; Allen, S.; Karita, E.; Musonda, R. and Kaslow, R. A. (1998): New TAP2 polymorphisms in Africans, Tissue Antigens 51 [5], pp.556-62.

Taylor, J. G.; Ferdig, M. T.; Su, X. Z. and Wellems, T. E. (2000): Toward quantitative genetic analysis of host and parasite traits in the manifestations of Plasmodium falciparum malaria, Curr Opin Genet Dev 10 [3], pp.314-9. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.biomednet.com/article/gda304

Taylor-Robinson, A. W.; Phillips, R. S.; Severn, A.; Moncada, S. and Liew, F. Y. (1993): The role of TH1 and TH2 cells in a rodent malaria infection, Science 260 [5116], pp.1931-4.

Taylor-Robinson, A. W. and Smith, E. C. (1999): A dichotomous role for nitric oxide in protection against blood stage malaria infection, Immunol Lett 67 [1], pp.1-9.

Termijtelen, A.; Naipal-van den Berge, S.; Suwandi-Thung, L. and van Rood, J. J. (1984): The influence of matching for SB on MLC typing is significant but marginal, Scand J Immunol 19 [3], pp.265-8.

Thompson, R.; Begtrup, K.; Cuamba, N.; Dgedge, M.; Mendis, C.; Gamage-Mendis, A.; Enosse, S.M.; Barretto, J.; Sinden, R.E. and Hogh, B. (1997): The Matola Malaria Project: A temporal and spatial study of malaria transmission and disease in a suburban area of Maputo, Mozambique, Transactions of the Royal Society of Tropical Medicine and Hygiene 57 [5], pp.550-559.

Todd, J. A.; Acha-Orbea, H.; Bell, J. I.; Chao, N.; Fronek, Z.; Jacob, C. O.; McDermott, M.; Sinha, A. A.; Timmerman, L.; Steinman, L. and et al. (1988): A molecular basis for MHC class II--associated autoimmunity [published erratum appears in Science 1988 Aug 19;241(4868):888], Science 240 [4855], pp.1003-9.

Todd, J. A.; Bell, J. I. and McDevitt, H. O. (1987): HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus, Nature 329 [6140], pp.599-604. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.ncbi.nlm.nih.gov/htbin-post/Omim/getmim%3ffield=medline_uid&search=3309680

Trape, J.F.; Rogier, C.; Konate, L. and al., et (1994): The Dielmo project: A longitudinal study of natural malaria infection and the mechanisms of protective immunity in a community living in a holoendemic area of Senegal, Am J Trop Med Hyg 51, pp.123-137.

Trape, J. F.; Rogier, C.; Konate, L.; Diagne, N.; Bouganali, H.; Canque, B.; Legros, F.; Badji, A.; Ndiaye, G.; Ndiaye, P. and et al. (1994): The Dielmo project: a longitudinal study of natural malaria infection and the mechanisms of protective immunity in a community living in a holoendemic area of Senegal, Am J Trop Med Hyg 51 [2], pp.123-37.

Travers, P.; Blundell, T. L.; Sternberg, M. J. and Bodmer, W. F. (1984): Structural and evolutionary analysis of HLA-D-region products, Nature 310 [5974], pp.235-8.

Trigg, P.I. and Kondrachine, A.V. (1998): The current global malaria situation, Sherman, I.W., Ed, Malaria - parasite biology, pathogenesis, and protection, 1. ed., pp. 11-24, ASM Press, Washington.

Triglia, T.; Wang, P.; Sims, P. F.; Hyde, J. E. and Cowman, A. F. (1998): Allelic exchange at the endogenous genomic locus in Plasmodium falciparum proves the role of dihydropteroate synthase in sulfadoxine- resistant malaria, Embo J 17 [14], pp.3807-15.. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.emboj.org/cgi/content/full/17/14/3807 http://www.emboj.org/cgi/content/full/17/14/3807

Trowsdale, J.; Hanson, I.; Mockridge, I.; Beck, S.; Townsend, A. and Kelly, A. (1990): Sequences encoded in the class II region of the MHC related to the 'ABC' superfamily of transporters, Nature 348 [6303], pp.741-4. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.ncbi.nlm.nih.gov/htbin-post/Omim/getmim%3ffield=medline_uid&search=2259383

Troye-Blomberg, M. (1994): Human T-cell responses to blood stage antigens in Plasmodium falciparum malaria, Immunol Lett 41 [2-3], pp.103-7.

Troye-Blomberg, M.; Olerup, O.; Larsson, A.; Sjoberg, K.; Perlmann, H.; Riley, E.; Lepers, J. P. and Perlmann, P. (1991): Failure to detect MHC class II associations of the human immune response induced by repeated malaria infections to the Plasmodium falciparum antigen Pf155/RESA, Int Immunol 3 [10], pp.1043-51.

Troye-Blomberg, M. and Perlmann, P. (1988): T cell functions in Plasmodium falciparum and other malarias, Prog Allergy 41, pp.253-87.

Tsai, E. Y.; Jain, J.; Pesavento, P. A.; Rao, A. and Goldfeld, A. E. (1996): Tumor necrosis factor alpha gene regulation in activated T cells involves ATF-2/Jun and NFATp, Mol Cell Biol 16 [2], pp.459-67.

Turner, G. D.; Morrison, H.; Jones, M.; Davis, T. M.; Looareesuwan, S.; Buley, I. D.; Gatter, K. C.; Newbold, C. I.; Pukritayakamee, S.; Nagachinta, B. and et al. (1994): An immunohistochemical study of the pathology of fatal malaria. Evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration, Am J Pathol 145 [5], pp.1057-69.

Turrini, F.; Schwarzer, E. and Arese, P. (1993): The involvement of hemozoin toxicity in depression of cellular immunity, Parasitology Today 9, pp.297-300.

Udhayakumar, V.; Ongecha, J. M.; Shi, Y. P.; Aidoo, M.; Orago, A. S.; Oloo, A. J.; Hawley, W. A.; Nahlen, B. L.; Hoffman, S. L.; Weiss, W. R. and Lal, A. A. (1997): Cytotoxic T cell reactivity and HLA-B35 binding of the variant Plasmodium falciparum circumsporozoite protein CD8+ CTL epitope in naturally exposed Kenyan adults, Eur J Immunol 27 [8], pp.1952-7.

Udomsangpetch, R.; Todd, J.; Carlson, J. and Greenwood, B. M. (1993): The effects of hemoglobin genotype and ABO blood group on the formation of rosettes by Plasmodium falciparum-infected red blood cells, Am J Trop Med Hyg 48 [2], pp.149-53.

Udomsangpetch, R.; Wahlin, B.; Carlson, J.; Berzins, K.; Torii, M.; Aikawa, M.; Perlmann, P. and Wahlgren, M. (1989): Plasmodium falciparum-infected erythrocytes form spontaneous erythrocyte rosettes, J Exp Med 169 [5], pp.1835-40.

Uebel, S. and Tampe, R. (1999): Specificity of the proteasome and the TAP transporter, Curr Opin Immunol 11 [2], pp.203-8. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.biomednet.com/article/imb212

Unanue, E. R. and Allen, P. M. (1987): The basis for the immunoregulatory role of macrophages and other accessory cells, Science 236 [4801], pp.551-7.

Urban, B. C.; Ferguson, D. J.; Pain, A.; Willcox, N.; Plebanski, M.; Austyn, J. M. and Roberts, D. J. (1999): Plasmodium falciparum-infected erythrocytes modulate the maturation of dendritic cells, Nature 400 [6739], pp.73-7.

Usanga, E. A. and Luzzatto, L. (1985): Adaptation of Plasmodium falciparum to glucose 6-phosphate dehydrogenase-deficient host red cells by production of parasite-encoded enzyme, Nature 313 [6005], pp.793-5.

Valdez, E.; del Carmen Martinez, M.; Gomez, A.; Cedillo, R.; Arellano, J.; Perez, M. E.; Ramos, F.; Moran, P.; Gonzalez, E.; Valenzuela, O.; Melendro, E. I.; Ramiro, M.; Kretschmer, R.; Munoz, O. and Ximenez, C. (1999): HLA characterization in adult asymptomatic cyst passers of Entamoeba histolytica/E. dispar, Parasitol Res 85 [10], pp.833-6.

van Endert, P. M. (1999): Genes regulating MHC class I processing of antigen, Curr Opin Immunol 11 [1], pp.82-8. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.biomednet.com/article/imb107

Vartdal, F. (1989): HLA associations in multiple sclerosis: implications for immunopathogenesis, Res Immunol 140 [2], pp.192-6; discussion 245-8.

Verdier, F.; Le Bras, J.; Clavier, F.; Hatin, I. and Blayo, M. C. (1985): Chloroquine uptake by Plasmodium falciparum-infected human erythrocytes during in vitro culture and its relationship to chloroquine resistance, Antimicrob Agents Chemother 27 [4], pp.561-4..

Vieira, P. P.; Alecrim, Md; da Silva, L. H.; Gonzalez-Jimenez, I. and Zalis, M. G. (2001): Analysis of the PfCRT K76T Mutation in Plasmodium falciparum Isolates from the Amazon Region of Brazil, J Infect Dis 183 [12], pp.1832-3..

Vinasco, J.; Fraile, A.; Nieto, A.; Beraun, Y.; Pareja, E.; Mataran, L. and Martin, J. (1998): Analysis of LMP and TAP polymorphisms by polymerase chain reaction- restriction fragment length polymorphism in rheumatoid arthritis, Ann Rheum Dis 57 [1], pp.33-7.

Vinitsky, A.; Anton, L. C.; Snyder, H. L.; Orlowski, M.; Bennink, J. R. and Yewdell, J. W. (1997): The generation of MHC class I-associated peptides is only partially inhibited by proteasome inhibitors: involvement of nonproteasomal cytosolic proteases in antigen processing?, J Immunol 159 [2], pp.554-64. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.jimmunol.org/cgi-bin/Retreiver.cgi/v159n2/554/554-abs-frame.html

Vogels, I.M.C.; van Noorden, C.J.F.; Wolf, B.H.M.; Saelman, D.E.M.; Tromp, A.; Schutgens, R.B.H. and Weening, R.S. (1986): Cytochemical determination of heterozygous Glucose-6-phosphate dehydrogenase deficiency in erythrocytes, British Journal of Haematology 63, pp.402-405.

Vogt, A. B.; Kropshofer, H.; Kalbacher, H.; Kalbus, M.; Rammensee, H. G.; Coligan, J. E. and Martin, R. (1994): Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides, J Immunol 153 [4], pp.1665-73.

Wahlgren, M.; Treutiger, C. J. and Gysin, J. (1999): Cytoadherence and rosetting in the pathogenesis of severe malaria, Wahlgren, M. and Perlmann, P., Eds, Malaria - molecular and clinical aspects, Harwood Academic Publishers, Amsterdam.

Waine, G. J.; Ross, A. G.; Williams, G. M.; Sleigh, A. C. and McManus, D. P. (1998): HLA class II antigens are associated with resistance or susceptibility to hepatosplenic disease in a Chinese population infected with Schistosoma japonicum, Int J Parasitol 28 [4], pp.537-42.

Wakelin, D. (1996): Intracellular protozoa, Wakelin, D., Ed, Immunity to parasites, 2. ed., pp. 45-69, Camebridge Unisversity Press, Camebridge.

Walford, R. L.; Finkelstein, S.; Neerhout, R.; Konrad, P. and Shanbrom, E. (1970): Acute childhood leukaemia in relation to the HL-A human transplantation genes, Nature 5231 [231], pp.461-2.

Walker-Jonah, A.; Dolan, S. A.; Gwadz, R. W.; Panton, L. J. and Wellems, T. E. (1992): An RFLP map of the Plasmodium falciparum genome, recombination rates and favored linkage groups in a genetic cross, Mol Biochem Parasitol 51 [2], pp.313-20.

Walliker, D.; Babiker, H. and Ranford-Cartwright, L. (1998): The genetic structure of malaria parasite populations, Sherman, I.W., Ed, Malaria - parasite biology, pathogenesis, and protection, 1. ed., pp. 235-252, ASM Press, Washington.

Walliker, D.; Quakyi, I. A.; Wellems, T. E.; McCutchan, T. F.; Szarfman, A.; London, W. T.; Corcoran, L. M.; Burkot, T. R. and Carter, R. (1987): Genetic analysis of the human malaria parasite Plasmodium falciparum, Science 236 [4809], pp.1661-6.

Wang, P.; Lee, C. S.; Bayoumi, R.; Djimde, A.; Doumbo, O.; Swedberg, G.; Dao, L. D.; Mshinda, H.; Tanner, M.; Watkins, W. M.; Sims, P. F. and Hyde, J. E. (1997): Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins, Mol Biochem Parasitol 89 [2], pp.161-77..

Wang, P.; Read, M.; Sims, P. F. and Hyde, J. E. (1997): Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization, Mol Microbiol 23 [5], pp.979-86.

Wang, R.; Charoenvit, Y.; Corradin, G.; De La Vega, P.; Franke, E.D. and Hoffman, S.L. (1996): Protection against malaria by Plasmodium yoelii sporozoite surface protein 2 linear peptide induction of CD4+ T cell- and IFN-gamma-dependent elimination of infected hepatocytes, J Immunol 157, pp.4061-4067.

Wang, R.; Doolan, D. L.; Le, T. P.; Hedstrom, R. C.; Coonan, K. M.; Charoenvit, Y.; Jones, T. R.; Hobart, P.; Margalith, M.; Ng, J.; Weiss, W. R.; Sedegah, M.; de Taisne, C.; Norman, J. A. and Hoffman, S. L. (1998): Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine, Science 282, pp.476-480.

Warrell, D. A.; White, N. J. and Warrell, M. J. (1982): Dexamethasone deleterious in cerebral malaria, Br Med J (Clin Res Ed) 285 [6355], p.1652.

Wattavidanage, J.; Carter, R.; Perera, K. L.; Munasingha, A.; Bandara, S.; McGuinness, D.; Wickramasinghe, A. R.; Alles, H. K.; Mendis, K. N. and Premawansa, S. (1999): TNFalpha*2 marks high risk of severe disease during Plasmodium falciparum malaria and other infections in Sri Lankans, Clin Exp Immunol 115 [2], pp.350-5.

Watts, T.E.; Wray, J.R.; Ngandu, H.H. and Draper, C.C. (1990): Malaria in an urban and a rural area in Zambia, Transactions of the Royal Society of Tropical Medicine and Hygiene 83 suppl., pp.196-200.

Weatherall, D. J. (1997): Thalassaemia and malaria, revisited, Ann Trop Med Parasitol 91 [7], pp.885-90.

Weatherall, D. J.; Abdalla, S. and Pippard, M. J. (1983): The anaemia of Plasmodium falciparum malaria, Ciba Found Symp 94, pp.74-97.

Weidanz, W. P. and Long, C. A. (1988): The role of T cells in immunity to malaria, Prog Allergy 41, pp.215-52.

Weiss, L. (1990): The spleen in malaria: the role of barrier cells, Immunol Lett 25 [1-3], pp.165-72.

Weiss, W.R.; Sedegah, M.; Berzofsky, J.A. and Hoffman, S.L. (1993): The role of CD4+ T cells in immunity to malaria sporozoites, J Immunol 151, pp.2690-2698.

Wellems, T. E.; Panton, L. J.; Gluzman, I. Y.; do Rosario, V. E.; Gwadz, R. W.; Walker-Jonah, A. and Krogstad, D. J. (1990): Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross, Nature 345 [6272], pp.253-5.

Wernsdorfer, W. H.; Landgraf, B.; Wiedermann, G. and Kollaritsch, H. (1994): Inverse correlation of sensitivity in vitro of Plasmodium falciparum to chloroquine and mefloquine in Ghana, Trans R Soc Trop Med Hyg 88 [4], pp.443-4..

White, NJ (1996): Malaria, Cook, G.C., Ed, Manson´s Tropical Disease, pp. 1087-1164, WB Saunders Company Ltd, London.

White, N.J. (1998): Malaria pathophysiology, Sherman, I.W., Ed, Malaria - parasite biology, pathogenesis, and protection, 1. ed., pp. 371-386, ASM Press, Washington.

WHO (1967): Standardization of prozedures for the study of Glucose-6-phosphate dehydrogase, WHO Technical Report Series 366.

WHO (1990): Practical chemotherapy of malaria: report of a WHO Scientific Group, WHO Tech Rep Ser 805.

WHO (1995): WHO Model describing information: Drugs used in parasitic diseases, 2. ed., WHO, Ed, Geneva.

WHO (1996): Fighting Disease, WHO report 1996, Fostering Development, Geneva.

WHO (1997): World malaria situation in 1994. I. Population at risk, Wkly Epidemiol Rec 72, pp.269-274.

WHO (2000): Severe falciparum malaria, Transactions of the Royal Society of Tropical Medicine and Hygiene 94, supplement 1, pp.1-90.

WHO/CTD (1996): Malaria in the world: Situation and progress, WHO, Geneva.

Wickramasinghe, S. N.; Abdalla, S. and Weatherall, D. J. (1982): Cell cycle distribution of erythroblasts in P. falciparum malaria, Scand J Haematol 29 [1], pp.83-8.

Wildling, E.; Winkler, S.; Kremsner, P. G.; Brandts, C.; Jenne, L. and Wernsdorfer, W. H. (1995): Malaria epidemiology in the province of Moyen Ogooué, Gabon, Trop Med Parasitol 46 [2], pp.77-82.

Williams, T. N.; Maitland, K.; Bennett, S.; Ganczakowski, M.; Peto, T. E.; Newbold, C. I.; Bowden, D. K.; Weatherall, D. J. and Clegg, J. B. (1996): High incidence of malaria in alpha-thalassaemic children, Nature 383 [6600], pp.522-5. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.ncbi.nlm.nih.gov/htbin-post/Omim/getmim%3ffield=medline_uid&search=8849722

Wilson, A. G.; di Giovine, F. S.; Blakemore, A. I. and Duff, G. W. (1992): Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product, Hum Mol Genet 1 [5], p.353. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.ncbi.nlm.nih.gov/htbin-post/Omim/getmim%3ffield=medline_uid&search=1363876

Wilson, A. G.; Symons, J. A.; McDowell, T. L.; McDevitt, H. O. and Duff, G. W. (1997): Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation, Proc Natl Acad Sci U S A 94 [7], pp.3195-9. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.pnas.org/cgi/content/full/94/7/3195

Wilson, C. M.; Serrano, A. E.; Wasley, A.; Bogenschutz, M. P.; Shankar, A. H. and Wirth, D. F. (1989): Amplification of a gene related to mammalian mdr genes in drug- resistant Plasmodium falciparum, Science 244 [4909], pp.1184-6..

Witte, A. M.; Klever, H. J.; Brabin, B. J.; Eggelte, T. A.; Van der Kaay, H. J. and Alpers, M. P. (1990): Field evaluation of the use of an ELISA to detect chloroquine and its metabolites in blood, urine and breast-milk, Trans R Soc Trop Med Hyg 84 [4], pp.521-5..

Wood, W. I.; Gitschier, J.; Lasky, L. A. and Lawn, R. M. (1985): Base composition-independent hybridization in tetramethylammonium chloride: a method for oligonucleotide screening of highly complex gene libraries, Proc Natl Acad Sci U S A 82 [6], pp.1585-8.

Woodruff, A. W.; Ansdell, V. E. and Pettitt, L. E. (1979): Cause of anaemia in malaria, Lancet 1 [8125], pp.1055-7.

Wozencraft, A. O.; Dockrell, H. M.; Taverne, J.; Targett, G. A. and Playfair, J. H. (1984): Killing of human malaria parasites by macrophage secretory products, Infect Immun 43 [2], pp.664-9.

Xu, W.; Humphries, S.; Tomita, M.; Okuyama, T.; Matsuki, M.; Burgner, D.; Kwiatkowski, D.; Liu, L. and Charles, I. G. (2000): Survey of the allelic frequency of a NOS2A promoter microsatellite in human populations: assessment of the NOS2A gene and predisposition to infectious disease, Nitric Oxide 4 [4], pp.379-83. http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.idealibrary.com/links/citation/1089-8603/4/379

Yamazaki, K.; Boyse, E. A.; Mike, V.; Thaler, H. T.; Mathieson, B. J.; Abbott, J.; Boyse, J.; Zayas, Z. A. and Thomas, L. (1976): Control of mating preferences in mice by genes in the major histocompatibility complex, J Exp Med 144 [5], pp.1324-35.

Yan, G.; Shi, L. and Faustman, D. (1999): Novel splicing of the human MHC-encoded peptide transporter confers unique properties, J Immunol 162 [2], pp.852-9.

Yayon, A.; Cabantchik, Z. I. and Ginsburg, H. (1984): Identification of the acidic compartment of Plasmodium falciparum- infected human erythrocytes as the target of the antimalarial drug chloroquine, Embo J 3 [11], pp.2695-700..

Yazdanbakhsh, M.; Sartono, E.; Kruize, Y. C.; Kurniawan, A.; Partono, F.; Maizels, R. M.; Schreuder, G. M.; Schipper, R. and de Vries, R. R. (1995): HLA and elephantiasis in lymphatic filariasis, Hum Immunol 44 [1], pp.58-61.

Yewdell, J.; Lapham, C.; Bacik, I.; Spies, T. and Bennink, J. (1994): MHC-encoded proteasome subunits LMP2 and LMP7 are not required for efficient antigen presentation, J Immunol 152 [3], pp.1163-70.

Yoeli, M.; Nussenzweig, R.; Upmains, R.S. and Most, H. (1966): Resistance of Plasmodium chabaudi-infected white mice to a fulminating and fatal strain of Plasmodium vinckei, Nature 211, pp.49-51.

Yoeli, M. and Sklarsh, J. (1970): The course of simultanously inoculated concomitant infections with Plasmodium vinckei and Plasmodium berghei in white mice, Tran R Soc Trop Med Hyg 64, pp.271-275.

Yorke, W. and McFie, J.W.S. (1924): Observations on malaria made during treatment of general paralysis, Trans R Soc Trop Med Hyg 18, pp.13-33.

Zevering, Y.; Khamboonruang, C. and Good, M. F. (1994): Natural amino acid polymorphisms of the circumsporozoite protein of Plasmodium falciparum abrogate specific human CD4+ T cell responsiveness, Eur J Immunol 24 [6], pp.1418-25.

Zimmerman, P. A.; Wieseman, M.; Spalding, T.; Boatin, B. A. and Nutman, T. B. (1997): A new intercellular adhesion molecule-1 allele identified in West Africans is prevalent in African-Americans in contrast to other North American racial groups, Tissue Antigens 50 [6], pp.654-6.

Zinkernagel, R. M. and Doherty, P. C. (1974): Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system, Nature 248 [450], pp.701-2.

Zinkernagel, R. M. and Doherty, P. C. (1979): MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness, Adv Immunol 27, pp.51-177.